ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0002250,adaptive immune response,44/213,385/15305,7.324808106380302e-28,2.1556910257077227e-24,1.664659021228955e-24,CD4/CD74/TNFRSF1B/FCGR2B/TBX21/PTPRC/STARD7/LAG3/SLA2/TLR8/PIK3CG/CTSC/UNC93B1/CD48/SASH3/IRF1/FGL2/CTSL/MYO1G/TLR4/CD8A/FCER1G/C1QC/TNFSF13/SLAMF6/CTSS/EOMES/CTLA4/C2/CD8B/C1QB/C1QA/PRF1/SH2D1A/LILRB4/HLA-DOA/HLA-DMA/HLA-DRA/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DQA1/HLA-DMB,44
GO:0042119,neutrophil activation,43/213,484/15305,8.495255837348423e-23,1.2500768964658204e-19,9.653293343597498e-20,TYROBP/SERPINB1/TNFRSF1B/GRN/CYBA/KCNAB2/FCGR2B/PTPRC/FTL/ADA2/CTSZ/CST3/ASAH1/MAN2B1/CTSC/RAP1A/CTSD/NPC2/ARHGAP9/FGL2/CD68/LGALS3/OSTF1/GNS/TMBIM1/CD53/CREG1/FCGR2A/FCER1G/CSTB/ITGB2/CTSS/BRI3/CTSB/CYBB/FTH1/CD14/C3AR1/FUCA1/GM2A/PSAP/PECAM1/CCL5,43
GO:0036230,granulocyte activation,43/213,491/15305,1.4977844748710688e-22,1.4693265698485184e-19,1.134637432016364e-19,TYROBP/SERPINB1/TNFRSF1B/GRN/CYBA/KCNAB2/FCGR2B/PTPRC/FTL/ADA2/CTSZ/CST3/ASAH1/MAN2B1/CTSC/RAP1A/CTSD/NPC2/ARHGAP9/FGL2/CD68/LGALS3/OSTF1/GNS/TMBIM1/CD53/CREG1/FCGR2A/FCER1G/CSTB/ITGB2/CTSS/BRI3/CTSB/CYBB/FTH1/CD14/C3AR1/FUCA1/GM2A/PSAP/PECAM1/CCL5,43
GO:0043312,neutrophil degranulation,41/213,470/15305,1.9231122278331256e-21,1.4149298216282222e-18,1.092631394708347e-18,TYROBP/SERPINB1/TNFRSF1B/GRN/CYBA/KCNAB2/PTPRC/FTL/ADA2/CTSZ/CST3/ASAH1/MAN2B1/CTSC/RAP1A/CTSD/NPC2/ARHGAP9/FGL2/CD68/LGALS3/OSTF1/GNS/TMBIM1/CD53/CREG1/FCGR2A/FCER1G/CSTB/ITGB2/CTSS/BRI3/CTSB/CYBB/FTH1/CD14/C3AR1/FUCA1/GM2A/PSAP/PECAM1,41
GO:0002283,neutrophil activation involved in immune response,41/213,473/15305,2.441326623792078e-21,1.436964850764017e-18,1.1096471959509675e-18,TYROBP/SERPINB1/TNFRSF1B/GRN/CYBA/KCNAB2/PTPRC/FTL/ADA2/CTSZ/CST3/ASAH1/MAN2B1/CTSC/RAP1A/CTSD/NPC2/ARHGAP9/FGL2/CD68/LGALS3/OSTF1/GNS/TMBIM1/CD53/CREG1/FCGR2A/FCER1G/CSTB/ITGB2/CTSS/BRI3/CTSB/CYBB/FTH1/CD14/C3AR1/FUCA1/GM2A/PSAP/PECAM1,41
GO:0002446,neutrophil mediated immunity,41/213,483/15305,5.338476878159753e-21,2.618522908737359e-18,2.0220651894643693e-18,TYROBP/SERPINB1/TNFRSF1B/GRN/CYBA/KCNAB2/PTPRC/FTL/ADA2/CTSZ/CST3/ASAH1/MAN2B1/CTSC/RAP1A/CTSD/NPC2/ARHGAP9/FGL2/CD68/LGALS3/OSTF1/GNS/TMBIM1/CD53/CREG1/FCGR2A/FCER1G/CSTB/ITGB2/CTSS/BRI3/CTSB/CYBB/FTH1/CD14/C3AR1/FUCA1/GM2A/PSAP/PECAM1,41
GO:0019882,antigen processing and presentation,27/213,222/15305,5.401192225604858e-18,2.270815531422157e-15,1.753560002267803e-15,CD74/CYBA/FCGR2B/LAG3/NCF4/LGMN/CTSD/FGL2/CD68/CTSL/CD8A/FCER1G/CTSS/CYBB/RILP/AP1S2/PSAP/HLA-DOA/HLA-DMA/HLA-DRA/HLA-E/HLA-A/IFI30/HLA-DPB1/HLA-DPA1/HLA-DQA1/HLA-DMB,27
GO:0042110,T cell activation,35/213,448/15305,7.538088500884285e-17,2.7730743072628064e-14,2.141412246501207e-14,CD4/CD74/TNFRSF1B/FCGR2B/TBX21/PTPRC/LAG3/SLA2/PIK3CG/TNFSF8/SASH3/IRF1/FGL2/RAC2/LGALS3/CTSL/CD8A/FCER1G/SLAMF6/EOMES/CTLA4/ICOS/CD8B/TIGIT/LILRB4/PSAP/CARD11/HLA-DOA/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,35
GO:0002478,antigen processing and presentation of exogenous peptide antigen,23/213,167/15305,1.1020871876843051e-16,3.603825103727677e-14,2.7829312727607188e-14,CD74/CYBA/FCGR2B/LAG3/NCF4/LGMN/CTSD/CTSL/FCER1G/CTSS/CYBB/RILP/AP1S2/HLA-DOA/HLA-DMA/HLA-DRA/HLA-E/HLA-A/IFI30/HLA-DPB1/HLA-DPA1/HLA-DQA1/HLA-DMB,23
GO:0019884,antigen processing and presentation of exogenous antigen,23/213,175/15305,3.167571593595436e-16,9.322163199951369e-14,7.198723232181627e-14,CD74/CYBA/FCGR2B/LAG3/NCF4/LGMN/CTSD/CTSL/FCER1G/CTSS/CYBB/RILP/AP1S2/HLA-DOA/HLA-DMA/HLA-DRA/HLA-E/HLA-A/IFI30/HLA-DPB1/HLA-DPA1/HLA-DQA1/HLA-DMB,23
GO:0002449,lymphocyte mediated immunity,26/213,239/15305,3.7026415451003027e-16,9.906249152027448e-14,7.649763728106751e-14,CD74/TNFRSF1B/FCGR2B/TBX21/PTPRC/STARD7/LAG3/SLA2/TLR8/CTSC/PRDX1/SASH3/FGL2/MYO1G/CD8A/FCER1G/C1QC/TNFSF13/SLAMF6/C2/C1QB/C1QA/PRF1/SH2D1A/HLA-E/HLA-A,26
GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,18/213,92/15305,4.416246476968998e-16,1.0830844484766468e-13,8.363751003312339e-14,CD74/FCGR2B/LAG3/LGMN/CTSD/CTSL/FCER1G/CTSS/RILP/AP1S2/HLA-DOA/HLA-DMA/HLA-DRA/IFI30/HLA-DPB1/HLA-DPA1/HLA-DQA1/HLA-DMB,18
GO:0048002,antigen processing and presentation of peptide antigen,23/213,184/15305,9.728859949246832e-16,2.0591953904053913e-13,1.590143551293968e-13,CD74/CYBA/FCGR2B/LAG3/NCF4/LGMN/CTSD/CTSL/FCER1G/CTSS/CYBB/RILP/AP1S2/HLA-DOA/HLA-DMA/HLA-DRA/HLA-E/HLA-A/IFI30/HLA-DPB1/HLA-DPA1/HLA-DQA1/HLA-DMB,23
GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,18/213,96/15305,9.795696726359319e-16,2.0591953904053913e-13,1.590143551293968e-13,CD74/FCGR2B/LAG3/LGMN/CTSD/CTSL/FCER1G/CTSS/RILP/AP1S2/HLA-DOA/HLA-DMA/HLA-DRA/IFI30/HLA-DPB1/HLA-DPA1/HLA-DQA1/HLA-DMB,18
GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,18/213,97/15305,1.1881979215783135e-15,2.331244322136651e-13,1.8002240790790027e-13,CD74/FCGR2B/LAG3/LGMN/CTSD/CTSL/FCER1G/CTSS/RILP/AP1S2/HLA-DOA/HLA-DMA/HLA-DRA/IFI30/HLA-DPB1/HLA-DPA1/HLA-DQA1/HLA-DMB,18
GO:0070663,regulation of leukocyte proliferation,24/213,222/15305,6.259429070316209e-15,1.1513437346212876e-12,8.890860107113615e-13,CD4/TYROBP/CD74/TNFRSF1B/FCGR2B/PTPRC/TNFSF8/CCL8/SASH3/IRF1/RAC2/LGALS3/TLR4/CTLA4/CSF1/CARD11/AIF1/LST1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,24
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,25/213,247/15305,7.735284849302067e-15,1.3391143124409402e-12,1.0340854482751185e-12,CD4/CD74/TNFRSF1B/FCGR2B/TBX21/PTPRC/STARD7/SLA2/TLR8/CTSC/SASH3/FGL2/MYO1G/TLR4/CD8A/FCER1G/C1QC/TNFSF13/SLAMF6/C2/C1QB/C1QA/PRF1/HLA-E/HLA-A,25
GO:0032944,regulation of mononuclear cell proliferation,23/213,207/15305,1.3060431849466976e-14,2.1353806073878506e-12,1.6489749919882572e-12,CD4/TYROBP/CD74/TNFRSF1B/FCGR2B/PTPRC/TNFSF8/SASH3/IRF1/RAC2/LGALS3/TLR4/CTLA4/CSF1/CARD11/AIF1/LST1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,23
GO:0051249,regulation of lymphocyte activation,31/213,421/15305,2.6666038646720188e-14,4.130429038805132e-12,3.1895832375772235e-12,CD4/TYROBP/CD74/TNFRSF1B/FCGR2B/TBX21/PTPRC/LAG3/TNFSF8/SASH3/IRF1/FGL2/RAC2/LGALS3/TLR4/SLAMF8/TNFSF13/CTLA4/ICOS/TIGIT/LILRB4/CARD11/HLA-DOA/AIF1/LST1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,31
GO:0002697,regulation of immune effector process,29/213,379/15305,7.378070284011228e-14,1.0856830422922521e-11,8.383817759568549e-12,TYROBP/CD74/TNFRSF1B/GRN/FCGR2B/TBX21/PTPRC/LAG3/RAP1A/SASH3/FGL2/RAC2/LGALS3/TLR4/SLAMF8/FCER1G/C1QC/ITGB2/TNFSF13/SLAMF6/C2/C3AR1/C1QB/C1QA/SH2D1A/HLA-E/HLA-A/APOBEC3G/HLA-DMB,29
GO:0050670,regulation of lymphocyte proliferation,22/213,206/15305,1.1531937070588082e-13,1.616118609463844e-11,1.2479925882405848e-11,CD4/TYROBP/CD74/TNFRSF1B/FCGR2B/PTPRC/TNFSF8/SASH3/IRF1/RAC2/LGALS3/TLR4/CTLA4/CARD11/AIF1/LST1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,22
GO:0070661,leukocyte proliferation,25/213,280/15305,1.3931513394538062e-13,1.863656541823887e-11,1.4391453310434296e-11,CD4/TYROBP/CD74/TNFRSF1B/FCGR2B/PTPRC/PIK3CG/TNFSF8/CCL8/SASH3/IRF1/RAC2/LGALS3/TLR4/CTLA4/CSF1/CARD11/AIF1/LST1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,25
GO:0032943,mononuclear cell proliferation,24/213,257/15305,1.6520206847026387e-13,2.1138682065564632e-11,1.6323627726649874e-11,CD4/TYROBP/CD74/TNFRSF1B/FCGR2B/PTPRC/PIK3CG/TNFSF8/SASH3/IRF1/RAC2/LGALS3/TLR4/CTLA4/CSF1/CARD11/AIF1/LST1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,24
GO:0050863,regulation of T cell activation,26/213,314/15305,2.5725833160487745e-13,3.1546302913048094e-11,2.43605586813566e-11,CD4/CD74/TNFRSF1B/FCGR2B/TBX21/PTPRC/LAG3/TNFSF8/SASH3/IRF1/FGL2/RAC2/LGALS3/CTLA4/ICOS/TIGIT/LILRB4/CARD11/HLA-DOA/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,26
GO:0046651,lymphocyte proliferation,23/213,255/15305,1.1327363969957154e-12,1.284268630635807e-10,9.91732737286588e-11,CD4/TYROBP/CD74/TNFRSF1B/FCGR2B/PTPRC/PIK3CG/TNFSF8/SASH3/IRF1/RAC2/LGALS3/TLR4/CTLA4/CARD11/AIF1/LST1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,23
GO:0007159,leukocyte cell-cell adhesion,26/213,335/15305,1.1522277382593824e-12,1.284268630635807e-10,9.91732737286588e-11,CD4/CD74/FCGR2B/TBX21/PTPRC/LAG3/SELPLG/SASH3/IRF1/FGL2/RAC2/LGALS3/ITGB2/CTLA4/ICOS/TIGIT/LILRB4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/PECAM1/CCL5,26
GO:0030595,leukocyte chemotaxis,21/213,207/15305,1.1782281015007403e-12,1.284268630635807e-10,9.91732737286588e-11,CD74/LGMN/PIK3CG/CCL8/CXCR4/RAC2/LGALS3/PLA2G7/SLAMF8/FCER1G/ITGB2/CCR5/CCR1/C3AR1/CSF1/AIF1/GPSM3/CCL5/CCL4/CCL18/CCL4L2,21
GO:0002521,leukocyte differentiation,31/213,490/15305,1.5295844029941666e-12,1.6077024635756544e-10,1.2414935060392504e-10,CD4/TYROBP/CD74/BAK1/FCGR2B/TBX21/PTPRC/SNX10/LAG3/TNFSF8/SASH3/IRF1/FGL2/CTSL/TLR4/CD8A/SLAMF8/FCER1G/C1QC/SLAMF6/EOMES/CTLA4/CCR1/HCLS1/CSF1/EVI2B/LILRB4/PSAP/CARD11/HLA-DOA/CEBPA,31
GO:0002683,negative regulation of immune system process,28/213,418/15305,5.251324777618913e-12,5.329189248459469e-10,4.1152850072156925e-10,TYROBP/CD74/GRN/FCGR2B/TBX21/CST7/PTPRC/LAG3/SLA2/SAMHD1/ELF1/IRF1/FGL2/CD68/LGALS3/TLR4/SLAMF8/FCER1G/C1QC/CTLA4/TIGIT/SH2D1A/LILRB4/HLA-DOA/LST1/HLA-E/HLA-A/GPX1,28
GO:0002253,activation of immune response,28/213,422/15305,6.594241639022324e-12,6.468951047880899e-10,4.995427262683929e-10,CD4/LCP2/FCGR2B/PTPRC/FYB1/SLA2/RAP1A/ELF1/LGALS3/MYO1G/TLR4/FCGR2A/FCER1G/C1QC/CTLA4/C2/C3AR1/C1QB/C1QA/SH2D1A/LILRB4/CARD11/FCGR3A/HLA-DRA/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DQA1,28
GO:0071674,mononuclear cell migration,14/213,83/15305,7.564070160394765e-12,7.180986607110256e-10,5.545272487705364e-10,LGMN/CCL8/LGALS3/PLA2G7/SLAMF8/CCR1/C3AR1/CSF1/AIF1/PECAM1/CCL5/CCL4/CCL18/CCL4L2,14
GO:0071346,cellular response to interferon-gamma,18/213,169/15305,2.2727658525162754e-11,2.090234344986062e-9,1.614112327494289e-9,CCL8/FASLG/IRF1/TLR4/GBP5/GBP4/HLA-DRA/AIF1/HLA-E/HLA-A/IFI30/HLA-DPB1/HLA-DPA1/HLA-DQA1/CCL5/CCL4/CCL18/CCL4L2,18
GO:0050900,leukocyte migration,27/213,418/15305,2.998680308818155e-11,2.6742776208641913e-9,2.065119868178117e-9,CD74/ATP1B3/TBX21/LGMN/PIK3CG/CCL8/SELPLG/CD48/CXCR4/RAC2/LGALS3/MYO1G/PLA2G7/SLAMF8/FCER1G/ITGB2/CCR5/CCR1/C3AR1/CSF1/AIF1/GPSM3/PECAM1/CCL5/CCL4/CCL18/CCL4L2,27
GO:0060326,cell chemotaxis,22/213,272/15305,3.131699702039383e-11,2.7107624185593834e-9,2.0932940113631666e-9,CD74/LGMN/PIK3CG/CCL8/CXCR4/RAC2/LGALS3/PLA2G7/SLAMF8/FCER1G/ITGB2/CCR5/CCR1/C3AR1/CSF1/AIF1/TMSB4X/GPSM3/CCL5/CCL4/CCL18/CCL4L2,22
GO:0050867,positive regulation of cell activation,24/213,329/15305,3.331583772731084e-11,2.80138601232788e-9,2.16327499709065e-9,CD4/TYROBP/CD74/TBX21/PTPRC/CTSC/PLEK/SASH3/TLR4/FCER1G/ITGB2/TNFSF13/CTLA4/ICOS/LILRB4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CEBPA/CCL5,24
GO:1903037,regulation of leukocyte cell-cell adhesion,23/213,302/15305,3.695589600824256e-11,3.0211444986738293e-9,2.33297600823964e-9,CD4/CD74/FCGR2B/TBX21/PTPRC/LAG3/SASH3/IRF1/FGL2/LGALS3/ITGB2/CTLA4/ICOS/TIGIT/LILRB4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,23
GO:0097529,myeloid leukocyte migration,19/213,198/15305,3.906362072552345e-11,3.107141507978798e-9,2.399384271590473e-9,CD74/LGMN/PIK3CG/CCL8/RAC2/LGALS3/PLA2G7/SLAMF8/FCER1G/ITGB2/CCR1/C3AR1/CSF1/AIF1/PECAM1/CCL5/CCL4/CCL18/CCL4L2,19
GO:0042129,regulation of T cell proliferation,17/213,155/15305,5.2170812428828217e-11,4.0404921310010905e-9,3.120132521713023e-9,CD4/TNFRSF1B/PTPRC/TNFSF8/SASH3/IRF1/RAC2/LGALS3/CTLA4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,17
GO:0042098,T cell proliferation,18/213,183/15305,8.64453870836117e-11,6.523301902232545e-9,5.037397860013973e-9,CD4/TNFRSF1B/PTPRC/PIK3CG/TNFSF8/SASH3/IRF1/RAC2/LGALS3/CTLA4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,18
GO:0002696,positive regulation of leukocyte activation,23/213,316/15305,9.195734802818741e-11,6.63916020411006e-9,5.1268654901634985e-9,CD4/TYROBP/CD74/TBX21/PTPRC/CTSC/SASH3/TLR4/FCER1G/ITGB2/TNFSF13/CTLA4/ICOS/LILRB4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CEBPA/CCL5,23
GO:0006909,phagocytosis,21/213,260/15305,9.249254786561755e-11,6.63916020411006e-9,5.1268654901634985e-9,TYROBP/MARCO/MSR1/CYBA/FCGR2B/PTPRC/NCF4/IL2RB/RAP1A/RAC2/MYO1G/TLR4/FCGR2A/IL2RG/FCER1G/ITGB2/C2/CD14/FCGR3A/AIF1/PECAM1,21
GO:0032103,positive regulation of response to external stimulus,28/213,475/15305,1.0642197305199898e-10,7.457139683143642e-9,5.758522301234731e-9,CD74/GRN/CYBA/LAG3/LGMN/TLR8/PIK3CG/CTSC/LY86/CXCR4/RAC2/TLR4/PLA2G7/GBP5/FCER1G/SLAMF6/CCR1/C3AR1/SH2D1A/CSF1/CARD11/AIF1/HLA-E/TMSB4X/GPSM3/CEBPA/CCL5/CCL4,28
GO:1902105,regulation of leukocyte differentiation,21/213,266/15305,1.4152612274191897e-10,9.686311144871339e-9,7.479924088122473e-9,CD4/TYROBP/CD74/FCGR2B/TBX21/PTPRC/LAG3/SASH3/IRF1/FGL2/TLR4/SLAMF8/C1QC/CTLA4/CCR1/HCLS1/CSF1/EVI2B/LILRB4/CARD11/HLA-DOA,21
GO:0034341,response to interferon-gamma,18/213,189/15305,1.477165777685853e-10,9.880224735748786e-9,7.62966725843004e-9,CCL8/FASLG/IRF1/TLR4/GBP5/GBP4/HLA-DRA/AIF1/HLA-E/HLA-A/IFI30/HLA-DPB1/HLA-DPA1/HLA-DQA1/CCL5/CCL4/CCL18/CCL4L2,18
GO:0002548,monocyte chemotaxis,11/213,56/15305,2.520746170668299e-10,1.6485679956170677e-8,1.2730505222158732e-8,LGMN/CCL8/LGALS3/PLA2G7/SLAMF8/CCR1/AIF1/CCL5/CCL4/CCL18/CCL4L2,11
GO:1990266,neutrophil migration,14/213,108/15305,2.9441758839203996e-10,1.883632527473421e-8,1.4545711060375612e-8,CD74/PIK3CG/CCL8/RAC2/LGALS3/SLAMF8/FCER1G/ITGB2/C3AR1/PECAM1/CCL5/CCL4/CCL18/CCL4L2,14
GO:0042116,macrophage activation,13/213,92/15305,4.322928625072691e-10,2.7068891369338146e-8,2.0903030014629207e-8,TYROBP/CD74/GRN/FCGR2B/CST7/PTPRC/TLR8/CTSC/TLR4/ITGB2/C1QA/AIF1/CEBPA,13
GO:0019724,B cell mediated immunity,14/213,113/15305,5.435404503033029e-10,3.31726952489735e-8,2.5616484805169728e-8,CD74/FCGR2B/TBX21/PTPRC/SLA2/TLR8/FGL2/FCER1G/C1QC/TNFSF13/C2/C1QB/C1QA/HLA-E,14
GO:0097530,granulocyte migration,15/213,134/15305,5.523146677538911e-10,3.31726952489735e-8,2.5616484805169728e-8,CD74/PIK3CG/CCL8/RAC2/LGALS3/SLAMF8/FCER1G/ITGB2/C3AR1/CSF1/PECAM1/CCL5/CCL4/CCL18/CCL4L2,15
GO:0002429,immune response-activating cell surface receptor signaling pathway,23/213,347/15305,5.856230044575998e-10,3.37938921984062e-8,2.6096183005654448e-08,CD4/LCP2/FCGR2B/PTPRC/FYB1/SLA2/RAP1A/ELF1/LGALS3/MYO1G/FCGR2A/FCER1G/CTLA4/C3AR1/SH2D1A/LILRB4/CARD11/FCGR3A/HLA-DRA/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DQA1,23
GO:0002757,immune response-activating signal transduction,23/213,347/15305,5.856230044575998e-10,3.37938921984062e-8,2.6096183005654448e-08,CD4/LCP2/FCGR2B/PTPRC/FYB1/SLA2/RAP1A/ELF1/LGALS3/MYO1G/FCGR2A/FCER1G/CTLA4/C3AR1/SH2D1A/LILRB4/CARD11/FCGR3A/HLA-DRA/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DQA1,23
GO:0030217,T cell differentiation,19/213,240/15305,1.0624002747707314e-9,6.012776939712044e-8,4.6431623344737034e-8,CD4/CD74/TBX21/PTPRC/LAG3/TNFSF8/SASH3/IRF1/FGL2/CTSL/CD8A/FCER1G/SLAMF6/EOMES/CTLA4/LILRB4/PSAP/CARD11/HLA-DOA,19
GO:0050727,regulation of inflammatory response,22/213,331/15305,1.34674609496097e-9,7.47825237258516e-8,5.7748258570421724e-8,TNFRSF1B/GRN/FCGR2B/CST7/PTPRC/ACP5/PLD3/PIK3CG/CTSC/APOE/TLR4/PLA2G7/GBP5/PIK3AP1/SLAMF8/FCER1G/HLA-E/TMSB4X/GPSM3/GPX1/CEBPA/CCL5,22
GO:0030098,lymphocyte differentiation,22/213,338/15305,1.9898852489195398e-9,1.0844874606611492e-7,8.374585287363131e-8,CD4/CD74/BAK1/FCGR2B/TBX21/PTPRC/LAG3/TNFSF8/SASH3/IRF1/FGL2/CTSL/CD8A/SLAMF8/FCER1G/SLAMF6/EOMES/CTLA4/LILRB4/PSAP/CARD11/HLA-DOA,22
GO:0002768,immune response-regulating cell surface receptor signaling pathway,23/213,378/15305,3.061887104009628e-9,1.638387954018243e-7,1.2651893315898156e-7,CD4/LCP2/FCGR2B/PTPRC/FYB1/SLA2/RAP1A/ELF1/LGALS3/MYO1G/FCGR2A/FCER1G/CTLA4/C3AR1/SH2D1A/LILRB4/CARD11/FCGR3A/HLA-DRA/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DQA1,23
GO:0032946,positive regulation of mononuclear cell proliferation,14/213,129/15305,3.1796175755853365e-9,1.671002593740651e-7,1.290374877009162e-7,CD4/CD74/PTPRC/SASH3/TLR4/CSF1/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,14
GO:0002764,immune response-regulating signaling pathway,23/213,381/15305,3.5604774235957605e-9,1.8383307118670742e-7,1.419588320875946e-7,CD4/LCP2/FCGR2B/PTPRC/FYB1/SLA2/RAP1A/ELF1/LGALS3/MYO1G/FCGR2A/FCER1G/CTLA4/C3AR1/SH2D1A/LILRB4/CARD11/FCGR3A/HLA-DRA/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DQA1,23
GO:0016064,immunoglobulin mediated immune response,13/213,110/15305,4.1206433878022026e-9,2.0908712914313588e-7,1.6146041877068883e-7,CD74/FCGR2B/TBX21/PTPRC/TLR8/FGL2/FCER1G/C1QC/TNFSF13/C2/C1QB/C1QA/HLA-E,13
GO:0030593,neutrophil chemotaxis,12/213,91/15305,4.654124264145501e-9,2.3215402897254594e-7,1.792730470346144e-7,CD74/PIK3CG/CCL8/RAC2/LGALS3/FCER1G/ITGB2/C3AR1/CCL5/CCL4/CCL18/CCL4L2,12
GO:0002699,positive regulation of immune effector process,17/213,211/15305,6.385385712917588e-9,3.0942578009202455e-7,2.389435267337951e-7,TYROBP/CD74/TBX21/PTPRC/LAG3/RAP1A/SASH3/RAC2/TLR4/FCER1G/ITGB2/TNFSF13/SLAMF6/SH2D1A/HLA-E/HLA-A/HLA-DMB,17
GO:0071621,granulocyte chemotaxis,13/213,114/15305,6.4135143002424394e-9,3.0942578009202455e-7,2.389435267337951e-7,CD74/PIK3CG/CCL8/RAC2/LGALS3/FCER1G/ITGB2/C3AR1/CSF1/CCL5/CCL4/CCL18/CCL4L2,13
GO:0045730,respiratory burst,8/213,31/15305,7.392998147537774e-9,3.483137153086417e-7,2.68973411074041e-7,GRN/CYBA/NCF4/PIK3CG/RAC2/SLAMF8/CYBB/CD52,8
GO:0001774,microglial cell activation,9/213,44/15305,7.687697251731735e-9,3.483137153086417e-7,2.68973411074041e-7,TYROBP/GRN/CST7/PTPRC/TLR8/CTSC/ITGB2/C1QA/AIF1,9
GO:0002269,leukocyte activation involved in inflammatory response,9/213,44/15305,7.687697251731735e-9,3.483137153086417e-7,2.68973411074041e-7,TYROBP/GRN/CST7/PTPRC/TLR8/CTSC/ITGB2/C1QA/AIF1,9
GO:0070665,positive regulation of leukocyte proliferation,14/213,138/15305,7.692963470968981e-9,3.483137153086417e-7,2.68973411074041e-7,CD4/CD74/PTPRC/SASH3/TLR4/CSF1/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,14
GO:0051251,positive regulation of lymphocyte activation,19/213,273/15305,8.98928333336718e-9,4.008403159106002e-7,3.095352905381139e-7,CD4/TYROBP/CD74/TBX21/PTPRC/SASH3/TLR4/TNFSF13/CTLA4/ICOS/LILRB4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,19
GO:0050852,T cell receptor signaling pathway,16/213,192/15305,1.1183831668519194e-8,4.887407279594611e-7,3.774133918716943e-7,CD4/LCP2/PTPRC/FYB1/SLA2/ELF1/LGALS3/CTLA4/SH2D1A/LILRB4/CARD11/HLA-DRA/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DQA1,16
GO:0001819,positive regulation of cytokine production,23/213,405/15305,1.1292684166239673e-8,4.887407279594611e-7,3.774133918716943e-7,CD4/TYROBP/CD74/CYBA/PTPRC/TLR8/POLR3GL/SASH3/IRF1/TLR4/GBP5/FCER1G/SLAMF6/CD14/C3AR1/TIGIT/CARD11/AIF1/HLA-E/HLA-A/GPSM3/HLA-DPB1/HLA-DPA1,23
GO:0002456,T cell mediated immunity,12/213,99/15305,1.2369019194615848e-8,5.275655578225281e-7,4.073945452505815e-7,TNFRSF1B/FCGR2B/TBX21/PTPRC/STARD7/CTSC/SASH3/MYO1G/CD8A/PRF1/HLA-E/HLA-A,12
GO:0022407,regulation of cell-cell adhesion,23/213,410/15305,1.4203438030316823e-8,5.971531160460345e-7,4.6113116853314324e-7,CD4/CD74/FCGR2B/TBX21/PTPRC/LAG3/SASH3/IRF1/FGL2/LGALS3/ITGB2/CTLA4/ICOS/TIGIT/LILRB4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,23
GO:0071675,regulation of mononuclear cell migration,9/213,48/15305,1.7331171664839032e-8,7.096521168270126e-7,5.480046927515854e-7,LGMN/LGALS3/PLA2G7/SLAMF8/CCR1/C3AR1/CSF1/AIF1/CCL5,9
GO:0150076,neuroinflammatory response,10/213,64/15305,1.736151967772508e-8,7.096521168270126e-7,5.480046927515854e-7,TYROBP/TNFRSF1B/GRN/CST7/PTPRC/TLR8/CTSC/ITGB2/C1QA/AIF1,10
GO:0002703,regulation of leukocyte mediated immunity,16/213,200/15305,2.0008985341821664e-8,8.066636145339884e-7,6.229185198701223e-7,TYROBP/TNFRSF1B/FCGR2B/TBX21/PTPRC/LAG3/SASH3/RAC2/TLR4/FCER1G/ITGB2/TNFSF13/SLAMF6/SH2D1A/HLA-E/HLA-A,16
GO:0050671,positive regulation of lymphocyte proliferation,13/213,128/15305,2.641020517982165e-8,1.050340997894799e-6,8.110900851100277e-7,CD4/CD74/PTPRC/SASH3/TLR4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,13
GO:0050851,antigen receptor-mediated signaling pathway,17/213,236/15305,3.391018465778827e-8,1.3306356459716116e-6,1.0275380866830158e-6,CD4/LCP2/FCGR2B/PTPRC/FYB1/SLA2/ELF1/LGALS3/CTLA4/SH2D1A/LILRB4/CARD11/HLA-DRA/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DQA1,17
GO:0061900,glial cell activation,9/213,52/15305,3.623153830849634e-8,1.4030186479197992e-6,1.083433396233291e-6,TYROBP/GRN/CST7/PTPRC/TLR8/CTSC/ITGB2/C1QA/AIF1,9
GO:0002687,positive regulation of leukocyte migration,13/213,134/15305,4.5841629019719455e-8,1.752102781883563e-6,1.3530017368909679e-6,CD74/LGMN/CCL8/RAC2/LGALS3/PLA2G7/CCR1/C3AR1/CSF1/AIF1/GPSM3/CCL5/CCL4,13
GO:0002690,positive regulation of leukocyte chemotaxis,11/213,91/15305,5.235036902493104e-8,1.975219692825283e-6,1.5252961771231597e-6,CD74/LGMN/RAC2/PLA2G7/CCR1/C3AR1/CSF1/AIF1/GPSM3/CCL5/CCL4,11
GO:0050921,positive regulation of chemotaxis,13/213,137/15305,5.973987492107033e-8,2.225499391046962e-6,1.7185661552910173e-6,CD74/LGMN/CXCR4/RAC2/PLA2G7/CCR1/C3AR1/CSF1/AIF1/TMSB4X/GPSM3/CCL5/CCL4,13
GO:0050866,negative regulation of cell activation,15/213,191/15305,7.189026830422054e-8,2.644663245241513e-6,2.0422511745896336e-6,TYROBP/CD74/GRN/FCGR2B/TBX21/CST7/PTPRC/LAG3/IRF1/FGL2/APOE/LGALS3/CTLA4/TIGIT/LST1,15
GO:0042102,positive regulation of T cell proliferation,11/213,94/15305,7.363978287131171e-8,2.675578777657659e-6,2.066124642224327e-6,CD4/PTPRC/SASH3/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,11
GO:0002688,regulation of leukocyte chemotaxis,12/213,116/15305,7.481636106412618e-8,2.685177446484431e-6,2.073536887515384e-6,CD74/LGMN/RAC2/PLA2G7/SLAMF8/CCR1/C3AR1/CSF1/AIF1/GPSM3/CCL5/CCL4,12
GO:0002831,regulation of response to biotic stimulus,21/213,379/15305,7.740980542663326e-8,2.744783823741948e-6,2.119565883526965e-6,GRN/CYBA/FCGR2B/LAG3/SAMHD1/TLR8/LY86/IRF1/FGL2/APOE/TLR4/GBP5/SLAMF8/FCER1G/SLAMF6/SH2D1A/CARD11/HLA-E/HLA-A/APOBEC3G/CCL5,21
GO:1903039,positive regulation of leukocyte cell-cell adhesion,16/213,222/15305,8.643608299312637e-8,3.0283499077234633e-6,2.3385401401273163e-6,CD4/CD74/PTPRC/SASH3/ITGB2/CTLA4/ICOS/LILRB4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,16
GO:0002695,negative regulation of leukocyte activation,14/213,170/15305,1.1004158999874886e-7,3.8100282278390344e-6,2.942164616808654e-6,TYROBP/CD74/GRN/FCGR2B/TBX21/CST7/PTPRC/LAG3/IRF1/FGL2/LGALS3/CTLA4/TIGIT/LST1,14
GO:0002440,production of molecular mediator of immune response,15/213,198/15305,1.1557350715611802e-7,3.955032925121573e-6,3.0541395587522494e-6,CD74/TNFRSF1B/FCGR2B/TBX21/PTPRC/STARD7/SAMHD1/SASH3/FGL2/TLR4/FCER1G/TNFSF13/CARD11/HLA-E/HLA-A,15
GO:1903706,regulation of hemopoiesis,23/213,464/15305,1.365160016072592e-7,4.618006812990389e-6,3.5660985779803105e-6,CD4/TYROBP/CD74/FCGR2B/TBX21/PTPRC/LAG3/SMAP1/SASH3/IRF1/FGL2/LGALS3/TLR4/SLAMF8/C1QC/CTLA4/CCR1/HCLS1/CSF1/EVI2B/LILRB4/CARD11/HLA-DOA,23
GO:0001909,leukocyte mediated cytotoxicity,11/213,100/15305,1.4044285300787993e-7,4.696855868206712e-6,3.626987077081493e-6,TYROBP/FCGR2B/PTPRC/LAG3/CTSC/PRDX1/SLAMF6/PRF1/SH2D1A/HLA-E/HLA-A,11
GO:0050870,positive regulation of T cell activation,15/213,204/15305,1.7083939111240103e-7,5.649217169031419e-6,4.362415676069472e-6,CD4/CD74/PTPRC/SASH3/CTLA4/ICOS/LILRB4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,15
GO:0002705,positive regulation of leukocyte mediated immunity,12/213,133/15305,3.392263818612423e-7,1.1092702686862624e-5,8.56596208699909e-6,TYROBP/TBX21/PTPRC/LAG3/SASH3/FCER1G/ITGB2/TNFSF13/SLAMF6/SH2D1A/HLA-E/HLA-A,12
GO:0050777,negative regulation of immune response,12/213,135/15305,3.991056442887178e-7,1.2907339682875786e-5,9.967253742271159e-6,GRN/FCGR2B/TBX21/PTPRC/SAMHD1/FGL2/LGALS3/SLAMF8/CTLA4/HLA-E/HLA-A/GPX1,12
GO:0071677,positive regulation of mononuclear cell migration,6/213,22/15305,4.194936630505884e-7,1.3419237503890019e-5,1.0362549411055155e-5,LGMN/LGALS3/PLA2G7/CCR1/AIF1/CCL5,6
GO:1902106,negative regulation of leukocyte differentiation,10/213,91/15305,5.313491095125586e-7,1.678020014804124e-5,1.295793841573083e-5,CD74/FCGR2B/TBX21/LAG3/IRF1/FGL2/TLR4/C1QC/CTLA4/LILRB4,10
GO:0045088,regulation of innate immune response,17/213,286/15305,5.359628997335633e-7,1.678020014804124e-5,1.295793841573083e-5,GRN/FCGR2B/LAG3/SAMHD1/TLR8/IRF1/APOE/TLR4/GBP5/SLAMF8/FCER1G/SLAMF6/SH2D1A/CARD11/HLA-E/HLA-A/CCL5,17
GO:0043030,regulation of macrophage activation,8/213,52/15305,5.487844511339066e-7,1.7000764628285126e-5,1.3128261828233843e-5,CD74/GRN/FCGR2B/CST7/PTPRC/CTSC/TLR4/CEBPA,8
GO:0002224,toll-like receptor signaling pathway,12/213,141/15305,6.390877786210056e-7,1.95920347133502e-5,1.5129281952223149e-5,CYBA/LGMN/TLR8/UNC93B1/IRF1/CTSL/TLR4/PIK3AP1/ITGB2/CTSS/CTSB/CD14,12
GO:0002685,regulation of leukocyte migration,14/213,197/15305,6.730781471787262e-7,2.042132976440197e-5,1.5769676828636676e-5,CD74/LGMN/CCL8/RAC2/LGALS3/PLA2G7/SLAMF8/CCR1/C3AR1/CSF1/AIF1/GPSM3/CCL5/CCL4,14
GO:0002407,dendritic cell chemotaxis,6/213,24/15305,7.393381441311326e-7,2.220277712426452e-5,1.7145338917068908e-5,PIK3CG/CXCR4/SLAMF8/CCR5/CCR1/CCL5,6
GO:0050864,regulation of B cell activation,11/213,118/15305,7.625558823680873e-7,2.266870668494223e-5,1.7505137161432226e-5,TYROBP/CD74/FCGR2B/TBX21/PTPRC/SASH3/TLR4/SLAMF8/TNFSF13/CTLA4/CARD11,11
GO:0002706,regulation of lymphocyte mediated immunity,12/213,145/15305,8.632375890001773e-7,2.5405082244275218e-5,1.9618210048961925e-5,TNFRSF1B/FCGR2B/TBX21/PTPRC/LAG3/SASH3/FCER1G/TNFSF13/SLAMF6/SH2D1A/HLA-E/HLA-A,12
GO:0048245,eosinophil chemotaxis,5/213,14/15305,9.00450692786544e-7,2.6237885038324738e-5,2.026131366051223e-5,CCL8/LGALS3/CCL5/CCL4/CCL4L2,5
GO:0022409,positive regulation of cell-cell adhesion,16/213,265/15305,9.513622013049252e-7,2.7449597631768578e-5,2.119701746767114e-5,CD4/CD74/PTPRC/SASH3/ITGB2/CTLA4/ICOS/LILRB4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,16
GO:0090025,regulation of monocyte chemotaxis,6/213,25/15305,9.615703402426157e-7,2.74747719546992e-5,2.1216457481694503e-5,LGMN/PLA2G7/SLAMF8/CCR1/AIF1/CCL5,6
GO:0050920,regulation of chemotaxis,14/213,208/15305,1.2917527843754792e-6,3.655411965785611e-5,2.822767471120101e-5,CD74/LGMN/CXCR4/RAC2/PLA2G7/SLAMF8/CCR1/C3AR1/CSF1/AIF1/TMSB4X/GPSM3/CCL5/CCL4,14
GO:0030888,regulation of B cell proliferation,8/213,59/15305,1.4875507290018523e-6,4.130058297596653e-5,3.189296945297914e-5,TYROBP/CD74/FCGR2B/PTPRC/SASH3/TLR4/CTLA4/CARD11,8
GO:0031343,positive regulation of cell killing,8/213,59/15305,1.4875507290018523e-6,4.130058297596653e-5,3.189296945297914e-5,TYROBP/PTPRC/LAG3/SLAMF6/PRF1/SH2D1A/HLA-E/HLA-A,8
GO:0070374,positive regulation of ERK1 and ERK2 cascade,13/213,181/15305,1.5104757518658428e-6,4.1545141474216595e-5,3.208182142920172e-5,CD4/MARCO/CD74/PTPRC/CCL8/RAP1A/APOE/TLR4/CCR1/CCL5/CCL4/CCL18/CCL4L2,13
GO:0002708,positive regulation of lymphocyte mediated immunity,10/213,102/15305,1.5418420205529746e-6,4.201519506006856e-5,3.2444804311636183e-5,TBX21/PTPRC/LAG3/SASH3/FCER1G/TNFSF13/SLAMF6/SH2D1A/HLA-E/HLA-A,10
GO:0009615,response to virus,17/213,309/15305,1.5629818848856139e-6,4.2200510891911576e-5,3.25879081551718e-5,TBX21/PTPRC/SAMHD1/TLR8/BNIP3L/CCL8/UNC93B1/NPC2/CXCR4/IRF1/FGL2/RNASE6/PRF1/APOBEC3G/IL10RB/CCL5/CCL4,17
GO:0032729,positive regulation of interferon-gamma production,8/213,60/15305,1.6960632258167183e-6,4.537740066889638e-5,3.504115315347651e-5,TLR8/SASH3/TLR4/SLAMF6/CD14/HLA-A/HLA-DPB1/HLA-DPA1,8
GO:0050766,positive regulation of phagocytosis,8/213,62/15305,2.1884687633472684e-6,5.802399613091001e-5,4.4807056046152236e-5,CYBA/FCGR2B/PTPRC/IL2RB/RAP1A/IL2RG/FCER1G/C2,8
GO:0002819,regulation of adaptive immune response,12/213,160/15305,2.451367433192717e-6,6.412132731748352e-5,4.951551251978716e-5,CD4/TNFRSF1B/FCGR2B/TBX21/PTPRC/CD48/SASH3/IRF1/FCER1G/TNFSF13/HLA-E/HLA-A,12
GO:0036336,dendritic cell migration,6/213,29/15305,2.4620149462710286e-6,6.412132731748352e-5,4.951551251978716e-5,PIK3CG/CXCR4/SLAMF8/CCR5/CCR1/CCL5,6
GO:0002700,regulation of production of molecular mediator of immune response,11/213,133/15305,2.5066830301869585e-6,6.471200138456332e-5,4.9971640463283875e-5,CD74/TNFRSF1B/FCGR2B/TBX21/PTPRC/SASH3/TLR4/FCER1G/TNFSF13/HLA-E/HLA-A,11
GO:0002573,myeloid leukocyte differentiation,13/213,190/15305,2.5984539451151007e-6,6.592456862477362e-5,5.090800424231854e-5,CD4/TYROBP/CD74/SNX10/TLR4/FCER1G/C1QC/CCR1/HCLS1/CSF1/EVI2B/LILRB4/CEBPA,13
GO:0042742,defense response to bacterium,13/213,190/15305,2.5984539451151007e-6,6.592456862477362e-5,5.090800424231854e-5,CD4/GRN/CYBA/ACP5/TNFSF8/TLR4/SLAMF8/FCER1G/GBP4/RNASE6/MPEG1/HLA-E/HLA-A,13
GO:0031341,regulation of cell killing,9/213,85/15305,2.726645102977628e-6,6.858561143643726e-5,5.2962903979565444e-5,TYROBP/FCGR2B/PTPRC/LAG3/SLAMF6/PRF1/SH2D1A/HLA-E/HLA-A,9
GO:0002285,lymphocyte activation involved in immune response,12/213,163/15305,2.9773757030761154e-6,7.425776859451701e-5,5.734303428136783e-5,CD74/FCGR2B/TBX21/PTPRC/FGL2/LGALS3/TLR4/FCER1G/TNFSF13/SLAMF6/EOMES/HLA-DMB,12
GO:0050858,negative regulation of antigen receptor-mediated signaling pathway,6/213,30/15305,3.041986775950417e-6,7.523165614808469e-5,5.8095085796346304e-5,FCGR2B/SLA2/ELF1/LGALS3/SH2D1A/LILRB4,6
GO:0002761,regulation of myeloid leukocyte differentiation,10/213,110/15305,3.0819734256903292e-06,7.558539826505532e-5,5.8368251105837025e-5,CD4/TYROBP/CD74/TLR4/C1QC/CCR1/HCLS1/CSF1/EVI2B/LILRB4,10
GO:0031348,negative regulation of defense response,13/213,194/15305,3.2734527793181888e-6,7.961794652506966e-5,6.14822492435665e-5,TNFRSF1B/GRN/FCGR2B/CST7/PTPRC/SAMHD1/ACP5/FGL2/APOE/SLAMF8/HLA-E/HLA-A/GPX1,13
GO:0001906,cell killing,11/213,137/15305,3.35061294354107e-6,8.082667125279811e-5,6.241564577312485e-5,TYROBP/FCGR2B/PTPRC/LAG3/CTSC/PRDX1/SLAMF6/PRF1/SH2D1A/HLA-E/HLA-A,11
GO:0050854,regulation of antigen receptor-mediated signaling pathway,8/213,66/15305,3.544576914700037e-6,8.481048666635942e-5,6.549201162890354e-5,FCGR2B/PTPRC/SLA2/ELF1/LGALS3/SH2D1A/LILRB4/CARD11,8
GO:0032760,positive regulation of tumor necrosis factor production,7/213,47/15305,3.5925674105330584e-6,8.526553136450638e-5,6.584340440866615e-5,CYBA/PTPRC/SASH3/TLR4/FCER1G/CD14/HLA-E,7
GO:0002286,T cell activation involved in immune response,9/213,88/15305,3.64983286410938e-6,8.533489920717939e-5,6.589697136409331e-5,CD74/FCGR2B/TBX21/FGL2/LGALS3/FCER1G/SLAMF6/EOMES/HLA-DMB,9
GO:0072677,eosinophil migration,5/213,18/15305,3.6824778115228616e-6,8.533489920717939e-5,6.589697136409331e-5,CCL8/LGALS3/CCL5/CCL4/CCL4L2,5
GO:0090026,positive regulation of monocyte chemotaxis,5/213,18/15305,3.6824778115228616e-6,8.533489920717939e-5,6.589697136409331e-5,LGMN/PLA2G7/CCR1/AIF1/CCL5,5
GO:0046631,alpha-beta T cell activation,11/213,139/15305,3.858984819835105e-6,8.872650253730245e-5,6.851602159559203e-5,TBX21/PTPRC/TNFSF8/SASH3/IRF1/CTSL/SLAMF6/EOMES/PSAP/HLA-E/HLA-A,11
GO:0045580,regulation of T cell differentiation,11/213,140/15305,4.137577004466432e-6,9.410023997615242e-5,7.266570742654758e-5,CD74/TBX21/PTPRC/LAG3/SASH3/IRF1/FGL2/CTLA4/LILRB4/CARD11/HLA-DOA,11
GO:0045058,T cell selection,7/213,48/15305,4.156653481787229e-6,9.410023997615242e-5,7.266570742654758e-5,CD4/CD74/TBX21/PTPRC/CTSL/SLAMF6/CARD11,7
GO:0045619,regulation of lymphocyte differentiation,12/213,169/15305,4.335885268397228e-6,9.740847591521406e-5,7.522038002787958e-5,CD74/TBX21/PTPRC/LAG3/SASH3/IRF1/FGL2/SLAMF8/CTLA4/LILRB4/CARD11/HLA-DOA,12
GO:0051250,negative regulation of lymphocyte activation,11/213,142/15305,4.747982042737202e-6,1.0585841781648172e-4,8.174556004999698e-5,TYROBP/CD74/FCGR2B/TBX21/LAG3/IRF1/FGL2/LGALS3/CTLA4/TIGIT/LST1,11
GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,7/213,49/15305,4.792618946516041e-6,1.0605020721501285e-4,8.189366288506635e-5,CYBA/PTPRC/SASH3/TLR4/FCER1G/CD14/HLA-E,7
GO:0031349,positive regulation of defense response,17/213,342/15305,6.120976206585666e-6,1.3443308191031058e-4,1.0381137179904522e-4,GRN/CYBA/LAG3/TLR8/PIK3CG/CTSC/TLR4/PLA2G7/GBP5/FCER1G/SLAMF6/SH2D1A/CARD11/HLA-E/GPSM3/CEBPA/CCL5,17
GO:0001910,regulation of leukocyte mediated cytotoxicity,8/213,71/15305,6.1862324858202465e-6,1.348598681908814e-4,1.0414094297766794e-4,TYROBP/FCGR2B/PTPRC/LAG3/SLAMF6/SH2D1A/HLA-E/HLA-A,8
GO:0001912,positive regulation of leukocyte mediated cytotoxicity,7/213,51/15305,6.30897581199782e-6,1.3582353336677225e-4,1.0488510060942514e-4,TYROBP/PTPRC/LAG3/SLAMF6/SH2D1A/HLA-E/HLA-A,7
GO:0002702,positive regulation of production of molecular mediator of immune response,9/213,94/15305,6.3227400853713215e-6,1.3582353336677225e-4,1.0488510060942514e-4,CD74/TBX21/PTPRC/SASH3/TLR4/FCER1G/TNFSF13/HLA-E/HLA-A,9
GO:0002577,regulation of antigen processing and presentation,5/213,20/15305,6.513962328368344e-6,1.389173270462901e-4,1.0727417747480742e-4,CD74/FCGR2B/FGL2/CD68/HLA-DOA,5
GO:0046466,membrane lipid catabolic process,6/213,34/15305,6.577539915743761e-6,1.3926402857578337e-4,1.075419059302596e-4,ASAH1/SGPL1/FUCA1/GM2A/PSAP/HEXA,6
GO:0002763,positive regulation of myeloid leukocyte differentiation,7/213,52/15305,7.2050055792433175e-6,1.5038532921782328e-4,1.1612995181475418e-4,CD4/TYROBP/CD74/CCR1/HCLS1/CSF1/EVI2B,7
GO:0006911,"phagocytosis, engulfment",7/213,52/15305,7.2050055792433175e-6,1.5038532921782328e-4,1.1612995181475418e-4,MARCO/MSR1/FCGR2B/RAC2/FCER1G/ITGB2/AIF1,7
GO:0002367,cytokine production involved in immune response,9/213,97/15305,8.194834431218747e-6,1.6984082909208995e-4,1.3115379938473891e-4,CD74/TNFRSF1B/TBX21/STARD7/SASH3/TLR4/FCER1G/HLA-E/HLA-A,9
GO:1901136,carbohydrate derivative catabolic process,12/213,181/15305,8.769598287449724e-6,1.804820123074443e-4,1.3937109092825877e-4,ADA2/SAMHD1/CST3/OMD/MGAT1/CTSL/GNS/FUCA1/GM2A/PSAP/HEXA/APOBEC3G,12
GO:0045581,negative regulation of T cell differentiation,6/213,37/15305,1.0981035979435902e-5,2.2442492282972125e-4,1.7330450789182833e-4,CD74/TBX21/LAG3/IRF1/FGL2/CTLA4,6
GO:0002604,regulation of dendritic cell antigen processing and presentation,4/213,11/15305,1.1148243022824968e-5,2.2472109052173891e-4,1.7353321331131294e-4,CD74/FCGR2B/FGL2/CD68,4
GO:0044803,multi-organism membrane organization,4/213,11/15305,1.1148243022824968e-5,2.2472109052173891e-4,1.7353321331131294e-4,CD4/CXCR4/CTSL/CCR5,4
GO:0002718,regulation of cytokine production involved in immune response,8/213,77/15305,1.1391846108383674e-5,2.2696262506852023e-4,1.7526416206983033e-4,CD74/TNFRSF1B/TBX21/SASH3/TLR4/FCER1G/HLA-E/HLA-A,8
GO:0071887,leukocyte apoptotic process,9/213,101/15305,1.1413682810105671e-5,2.2696262506852023e-4,1.7526416206983033e-4,CD74/BAK1/FASLG/LGALS3/CTSL/FCER1G/CCR5/HCLS1/CCL5,9
GO:0002221,pattern recognition receptor signaling pathway,12/213,189/15305,1.3587724134244203e-5,2.6703777546320333e-4,2.0621083292202944e-4,CYBA/LGMN/TLR8/UNC93B1/IRF1/CTSL/TLR4/PIK3AP1/ITGB2/CTSS/CTSB/CD14,12
GO:0050860,negative regulation of T cell receptor signaling pathway,5/213,23/15305,1.3664553205592085e-5,2.6703777546320333e-4,2.0621083292202944e-4,SLA2/ELF1/LGALS3/SH2D1A/LILRB4,5
GO:0042100,B cell proliferation,8/213,79/15305,1.3791961219981959e-5,2.6703777546320333e-4,2.0621083292202944e-4,TYROBP/CD74/FCGR2B/PTPRC/SASH3/TLR4/CTLA4/CARD11,8
GO:0070098,chemokine-mediated signaling pathway,8/213,79/15305,1.3791961219981959e-5,2.6703777546320333e-4,2.0621083292202944e-4,CCL8/CXCR4/CCR5/CCR1/CCL5/CCL4/CCL18/CCL4L2,8
GO:0072676,lymphocyte migration,9/213,105/15305,1.5654976611930285e-5,3.011280795353649e-4,2.3253590990820425e-4,TBX21/PIK3CG/CCL8/MYO1G/AIF1/CCL5/CCL4/CCL18/CCL4L2,9
GO:0002468,dendritic cell antigen processing and presentation,4/213,12/15305,1.6540156733671083e-5,3.1404955656254193e-4,2.4251408073341847e-4,CD74/FCGR2B/FGL2/CD68,4
GO:0150079,negative regulation of neuroinflammatory response,4/213,12/15305,1.6540156733671083e-5,3.1404955656254193e-4,2.4251408073341847e-4,TNFRSF1B/GRN/CST7/PTPRC,4
GO:0050729,positive regulation of inflammatory response,10/213,133/15305,1.6801011448617672e-5,3.168629119479595e-4,2.446865986714754e-4,GRN/PIK3CG/CTSC/TLR4/PLA2G7/GBP5/FCER1G/HLA-E/GPSM3/CEBPA,10
GO:0032609,interferon-gamma production,9/213,106/15305,1.6903661969361075e-5,3.168629119479595e-4,2.446865986714754e-4,TLR8/SASH3/TLR4/SLAMF6/EOMES/CD14/HLA-A/HLA-DPB1/HLA-DPA1,9
GO:0050868,negative regulation of T cell activation,9/213,107/15305,1.8236152905979788e-5,3.396772025461932e-4,2.623041580546993e-4,CD74/FCGR2B/TBX21/LAG3/IRF1/FGL2/LGALS3/CTLA4/TIGIT,9
GO:0002920,regulation of humoral immune response,7/213,60/15305,1.8930142464297693e-5,3.503862218391705e-4,2.7057383370022325e-4,FCGR2B/PTPRC/C1QC/C2/C3AR1/C1QB/C1QA,7
GO:0002455,humoral immune response mediated by circulating immunoglobulin,6/213,41/15305,2.0276384836938443e-5,3.729587535944365e-4,2.8800470304572436e-4,FCGR2B/PTPRC/C1QC/C2/C1QB/C1QA,6
GO:0099024,plasma membrane invagination,7/213,61/15305,2.113400192480394e-5,3.8631905381799996e-4,2.983217401480988e-4,MARCO/MSR1/FCGR2B/RAC2/FCER1G/ITGB2/AIF1,7
GO:0002377,immunoglobulin production,9/213,110/15305,2.278277671698478e-5,4.1136149831537194e-4,3.1765991554013554e-4,FCGR2B/TBX21/PTPRC/SAMHD1/SASH3/FGL2/TNFSF13/CARD11/HLA-E,9
GO:0055074,calcium ion homeostasis,18/213,418/15305,2.2897711866024425e-5,4.1136149831537194e-4,3.1765991554013554e-4,CD4/BAK1/HERPUD1/CYBA/PTPRC/SNX10/PIK3CG/CCL8/FASLG/CXCR4/APOE/CLIC2/CCR5/CCR1/CD52/C3AR1/TRPV2/CCL5,18
GO:0051235,maintenance of location,15/213,303/15305,2.2923304697152906e-5,4.1136149831537194e-4,3.1765991554013554e-4,CD4/MSR1/CYBA/KEAP1/PTPRC/FTL/FASLG/SRGN/APOE/OSBPL11/CLIC2/CCR5/FTH1/GM2A/TMSB4X,15
GO:0006801,superoxide metabolic process,7/213,62/15305,2.3545251599898433e-5,4.1996166944546114e-4,3.243011049708498e-4,TYROBP/CYBA/NCF4/ACP5/PRDX1/ITGB2/CYBB,7
GO:0002698,negative regulation of immune effector process,9/213,111/15305,2.449774531427755e-5,4.3431846060192064e-4,3.353876482785366e-4,GRN/FCGR2B/TBX21/PTPRC/FGL2/LGALS3/SLAMF8/HLA-E/HLA-A,9
GO:0002833,positive regulation of response to biotic stimulus,13/213,234/15305,2.4706220572195217e-5,4.353916595447337e-4,3.362163896335926e-4,GRN/CYBA/LAG3/TLR8/LY86/TLR4/GBP5/FCER1G/SLAMF6/SH2D1A/CARD11/HLA-E/CCL5,13
GO:0036037,"CD8-positive, alpha-beta T cell activation",5/213,26/15305,2.5819732753909627e-5,4.523063898497383e-4,3.4927821438402807e-4,TNFSF8/IRF1/EOMES/HLA-E/HLA-A,5
GO:1903707,negative regulation of hemopoiesis,10/213,140/15305,2.625203248796032e-5,4.5715817521933263e-4,3.5302484049521223e-4,CD74/FCGR2B/TBX21/LAG3/IRF1/FGL2/TLR4/C1QC/CTLA4/LILRB4,10
GO:0001913,T cell mediated cytotoxicity,6/213,43/15305,2.686231437542457e-5,4.623145684612544e-4,3.5700668966784637e-4,FCGR2B/PTPRC/CTSC/PRF1/HLA-E/HLA-A,6
GO:0050856,regulation of T cell receptor signaling pathway,6/213,43/15305,2.686231437542457e-5,4.623145684612544e-4,3.5700668966784637e-4,SLA2/ELF1/LGALS3/SH2D1A/LILRB4/CARD11,6
GO:0060333,interferon-gamma-mediated signaling pathway,8/213,87/15305,2.808831445597856e-5,4.750799393330167e-4,3.668643128279354e-4,IRF1/HLA-DRA/HLA-E/HLA-A/IFI30/HLA-DPB1/HLA-DPA1/HLA-DQA1,8
GO:1990868,response to chemokine,8/213,87/15305,2.808831445597856e-5,4.750799393330167e-4,3.668643128279354e-4,CCL8/CXCR4/CCR5/CCR1/CCL5/CCL4/CCL18/CCL4L2,8
GO:1990869,cellular response to chemokine,8/213,87/15305,2.808831445597856e-5,4.750799393330167e-4,3.668643128279354e-4,CCL8/CXCR4/CCR5/CCR1/CCL5/CCL4/CCL18/CCL4L2,8
GO:0050764,regulation of phagocytosis,8/213,88/15305,3.053216261516541e-5,5.134637404367532e-4,3.965048967587496e-4,CYBA/FCGR2B/PTPRC/IL2RB/RAP1A/IL2RG/FCER1G/C2,8
GO:0030574,collagen catabolic process,6/213,44/15305,3.074565854661762e-5,5.141163244471344e-4,3.9700883254872876e-4,CST3/CTSD/PEPD/CTSL/CTSS/CTSB,6
GO:0019377,glycolipid catabolic process,4/213,14/15305,3.2723393885757e-5,5.440957525750444e-4,4.2015942550906556e-4,FUCA1/GM2A/PSAP/HEXA,4
GO:0045620,negative regulation of lymphocyte differentiation,6/213,45/15305,3.506744069742964e-5,5.797948200704238e-4,4.477268152912513e-4,CD74/TBX21/LAG3/IRF1/FGL2/CTLA4,6
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,10/213,145/15305,3.551722085628364e-5,5.839507317320823e-4,4.5093607661697376e-4,CD4/TNFRSF1B/FCGR2B/TBX21/PTPRC/SASH3/FCER1G/TNFSF13/HLA-E/HLA-A,10
GO:1903038,negative regulation of leukocyte cell-cell adhesion,9/213,117/15305,3.7263708464044834e-5,6.09261633387133e-4,4.704815589115368e-4,CD74/FCGR2B/TBX21/LAG3/IRF1/FGL2/LGALS3/CTLA4/TIGIT,9
GO:0055094,response to lipoprotein particle,5/213,28/15305,3.7712610450974635e-5,6.131945445150185e-4,4.7351861566533434e-4,CD68/APOE/TLR4/FCER1G/ITGB2,5
GO:1902107,positive regulation of leukocyte differentiation,10/213,147/15305,3.993809913429136e-5,6.458122294077993e-4,4.987065126138522e-4,CD4/TYROBP/CD74/PTPRC/SASH3/CCR1/HCLS1/CSF1/EVI2B/LILRB4,10
GO:0045639,positive regulation of myeloid cell differentiation,8/213,92/15305,4.2162485233395165e-5,6.780557051468961e-4,5.236054392804151e-4,CD4/TYROBP/CD74/SMAP1/CCR1/HCLS1/CSF1/EVI2B,8
GO:0002532,production of molecular mediator involved in inflammatory response,7/213,68/15305,4.3252733682504573e-05,6.91808669715277e-4,5.342256980579369e-4,GRN/PLD3/TLR4/GBP5/SLAMF8/FCER1G/GPSM3,7
GO:1901216,positive regulation of neuron death,8/213,93/15305,4.558611764233747e-5,7.251888876832387e-4,5.600024352193833e-4,TYROBP/GRN/FCGR2B/CTSZ/FASLG/TLR4/ITGB2/C1QA,8
GO:0002709,regulation of T cell mediated immunity,7/213,69/15305,4.757395780207898e-5,7.44734881976162e-4,5.750961640240118e-4,TNFRSF1B/FCGR2B/TBX21/PTPRC/SASH3/HLA-E/HLA-A,7
GO:0010324,membrane invagination,7/213,69/15305,4.757395780207898e-5,7.44734881976162e-4,5.750961640240118e-4,MARCO/MSR1/FCGR2B/RAC2/FCER1G/ITGB2/AIF1,7
GO:0050830,defense response to Gram-positive bacterium,7/213,69/15305,4.757395780207898e-5,7.44734881976162e-4,5.750961640240118e-4,ACP5/TNFSF8/GBP4/RNASE6/MPEG1/HLA-E/HLA-A,7
GO:0034612,response to tumor necrosis factor,14/213,288/15305,5.255030588023999e-5,8.182833344208798e-4,6.318914530517301e-4,TNFRSF1B/CYBA/RFFL/ASAH1/TNFSF8/CCL8/TNFSF13/CD14/TMSB4X/CEBPA/CCL5/CCL4/CCL18/CCL4L2,14
GO:0032649,regulation of interferon-gamma production,8/213,95/15305,5.313161956249253e-5,8.194321213277235e-4,6.327785646392171e-4,TLR8/SASH3/TLR4/SLAMF6/CD14/HLA-A/HLA-DPB1/HLA-DPA1,8
GO:0030149,sphingolipid catabolic process,5/213,30/15305,5.345938406215525e-5,8.194321213277235e-4,6.327785646392171e-4,ASAH1/SGPL1/GM2A/PSAP/HEXA,5
GO:0071402,cellular response to lipoprotein particle stimulus,5/213,30/15305,5.345938406215525e-5,8.194321213277235e-4,6.327785646392171e-4,CD68/APOE/TLR4/FCER1G/ITGB2,5
GO:0006874,cellular calcium ion homeostasis,17/213,407/15305,5.681528695211795e-5,8.663595310885136e-4,6.69016659556164e-4,CD4/BAK1/HERPUD1/CYBA/PTPRC/PIK3CG/CCL8/FASLG/CXCR4/APOE/CLIC2/CCR5/CCR1/CD52/C3AR1/TRPV2/CCL5,17
GO:0045785,positive regulation of cell adhesion,17/213,408/15305,5.856452862730554e-5,8.884299368564959e-4,6.86059779198875e-4,CD4/CD74/PTPRC/SASH3/ITGB2/CTLA4/ICOS/CSF1/LILRB4/CARD11/AIF1/HLA-E/HLA-A/HLA-DPB1/HLA-DPA1/HLA-DMB/CCL5,17
GO:0042554,superoxide anion generation,5/213,31/15305,6.302301146881844e-5,9.463098099629218e-4,7.307555411448928e-4,TYROBP/CYBA/ACP5/ITGB2/CYBB,5
GO:0150077,regulation of neuroinflammatory response,5/213,31/15305,6.302301146881844e-5,9.463098099629218e-4,7.307555411448928e-4,TNFRSF1B/GRN/CST7/PTPRC/CTSC,5
GO:0072507,divalent inorganic cation homeostasis,18/213,454/15305,6.717069265006274e-5,0.0010034687739549982,7.74894605564977e-4,CD4/BAK1/HERPUD1/CYBA/PTPRC/SNX10/PIK3CG/CCL8/FASLG/CXCR4/APOE/CLIC2/CCR5/CCR1/CD52/C3AR1/TRPV2/CCL5,18
GO:1903708,positive regulation of hemopoiesis,11/213,189/15305,6.902675233945351e-5,0.0010259885461364226,7.922847331253597e-4,CD4/TYROBP/CD74/PTPRC/SMAP1/SASH3/CCR1/HCLS1/CSF1/EVI2B/LILRB4,11
GO:0046632,alpha-beta T cell differentiation,8/213,99/15305,7.136444106840216e-5,0.0010554047741925003,8.150004139998956e-4,TBX21/TNFSF8/SASH3/IRF1/CTSL/SLAMF6/EOMES/PSAP,8
GO:0032623,interleukin-2 production,6/213,51/15305,7.233814523017554e-5,0.001064455807062033,8.219897660628894e-4,CD4/TBX21/PTPRC/SASH3/FCER1G/CARD11,6
GO:0001911,negative regulation of leukocyte mediated cytotoxicity,4/213,17/15305,7.529237560033618e-5,0.0010877705530650064,8.399937850983956e-4,FCGR2B/PTPRC/HLA-E/HLA-A,4
GO:0043031,negative regulation of macrophage activation,4/213,17/15305,7.529237560033618e-5,0.0010877705530650064,8.399937850983956e-4,GRN/FCGR2B/CST7/PTPRC,4
GO:0044764,multi-organism cellular process,4/213,17/15305,7.529237560033618e-5,0.0010877705530650064,8.399937850983956e-4,CD4/CXCR4/CTSL/CCR5,4
GO:0050728,negative regulation of inflammatory response,9/213,128/15305,7.54010169300922e-5,0.0010877705530650064,8.399937850983956e-4,TNFRSF1B/GRN/FCGR2B/CST7/PTPRC/ACP5/APOE/SLAMF8/GPX1,9
GO:0070372,regulation of ERK1 and ERK2 cascade,13/213,261/15305,7.622654837759623e-5,0.0010943157652451986,8.450481024248024e-4,CD4/MARCO/CD74/PTPRC/CCL8/RAP1A/APOE/TLR4/CCR1/CCL5/CCL4/CCL18/CCL4L2,13
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,8/213,100/15305,7.665508374124444e-5,0.0010951257837402057,8.456736116369276e-4,CD4/TBX21/PTPRC/SASH3/FCER1G/TNFSF13/HLA-E/HLA-A,8
GO:0032653,regulation of interleukin-10 production,6/213,52/15305,8.083377214116667e-5,0.0011492453691374566,8.874656193886542e-4,TYROBP/FCGR2B/SASH3/TLR4/FCER1G/TIGIT,6
GO:0050871,positive regulation of B cell activation,7/213,75/15305,8.156801584940152e-5,0.001154108993484561,8.912213877472565e-4,CD74/TBX21/PTPRC/SASH3/TLR4/TNFSF13/CARD11,7
GO:0032680,regulation of tumor necrosis factor production,8/213,101/15305,8.22672472622028e-5,0.0011584330559457551,8.945604978045623e-4,CYBA/PTPRC/ACP5/SASH3/TLR4/FCER1G/CD14/HLA-E,8
GO:0002720,positive regulation of cytokine production involved in immune response,6/213,53/15305,9.010562871370589e-5,0.0012567813521537272,9.705066220648092e-4,CD74/SASH3/TLR4/FCER1G/HLA-E/HLA-A,6
GO:0048247,lymphocyte chemotaxis,6/213,53/15305,9.010562871370589e-5,0.0012567813521537272,9.705066220648092e-4,PIK3CG/CCL8/CCL5/CCL4/CCL18/CCL4L2,6
GO:0006959,humoral immune response,11/213,196/15305,9.565107264512776e-5,0.0013186119116477268,0.0010182531671039012,FCGR2B/PTPRC/C1QC/C2/RNASE6/C3AR1/C1QB/C1QA/SH2D1A/HLA-E/HLA-A,11
GO:1903978,regulation of microglial cell activation,4/213,18/15305,9.575234639714023e-5,0.0013186119116477268,0.0010182531671039012,GRN/CST7/PTPRC/CTSC,4
GO:0071356,cellular response to tumor necrosis factor,13/213,267/15305,9.588275538315105e-5,0.0013186119116477268,0.0010182531671039012,TNFRSF1B/CYBA/RFFL/ASAH1/TNFSF8/CCL8/TNFSF13/TMSB4X/CEBPA/CCL5/CCL4/CCL18/CCL4L2,13
GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,7/213,77/15305,9.653532996273708e-5,0.0013214115166527219,0.0010204150667786993,CYBA/NCF4/FCER1G/CYBB/HLA-E/HLA-A/IFI30,7
GO:0002712,regulation of B cell mediated immunity,6/213,54/15305,1.0020435805124363e-4,0.0013589927453677882,0.0010494358914995634,FCGR2B/TBX21/PTPRC/FCER1G/TNFSF13/HLA-E,6
GO:0002889,regulation of immunoglobulin mediated immune response,6/213,54/15305,1.0020435805124363e-4,0.0013589927453677882,0.0010494358914995634,FCGR2B/TBX21/PTPRC/FCER1G/TNFSF13/HLA-E,6
GO:0042113,B cell activation,12/213,232/15305,1.0090870476595134e-4,0.0013597775103043235,0.0010500418995107157,TYROBP/CD74/BAK1/FCGR2B/TBX21/PTPRC/SASH3/TLR4/SLAMF8/TNFSF13/CTLA4/CARD11,12
GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,8/213,104/15305,1.0118629791255414e-4,0.0013597775103043235,0.0010500418995107157,CYBA/PTPRC/ACP5/SASH3/TLR4/FCER1G/CD14/HLA-E,8
GO:0032755,positive regulation of interleukin-6 production,7/213,78/15305,1.0481620054326553e-4,0.0014021549009037748,0.0010827663969995706,TYROBP/CD74/CYBA/TLR8/TLR4/FCER1G/AIF1,7
GO:0002821,positive regulation of adaptive immune response,8/213,105/15305,1.0824042750435792e-4,0.0014414098558612008,0.001113079699842385,CD4/TBX21/PTPRC/SASH3/FCER1G/TNFSF13/HLA-E/HLA-A,8
GO:0002886,regulation of myeloid leukocyte mediated immunity,6/213,55/15305,1.111825145111237e-4,0.0014544264377944138,0.0011231313121941946,TYROBP/FCGR2B/RAC2/FCER1G/ITGB2/HLA-E,6
GO:0032613,interleukin-10 production,6/213,55/15305,1.111825145111237e-4,0.0014544264377944138,0.0011231313121941946,TYROBP/FCGR2B/SASH3/TLR4/FCER1G/TIGIT,6
GO:0042267,natural killer cell mediated cytotoxicity,6/213,55/15305,1.111825145111237e-4,0.0014544264377944138,0.0011231313121941946,LAG3/PRDX1/SLAMF6/SH2D1A/HLA-E/HLA-A,6
GO:0072511,divalent inorganic cation transport,17/213,430/15305,1.1119468178856374e-4,0.0014544264377944138,0.0011231313121941946,CD4/BAK1/CYBA/PTPRC/PIK3CG/CCL8/FASLG/CXCR4/LGALS3/CLIC2/CCR5/CCR1/MMGT1/TCN2/TRPV2/CCL5/CCL4,17
GO:0051651,maintenance of location in cell,11/213,200/15305,1.144821176372718e-4,0.0014908003194977473,0.0011512198042797851,CD4/CYBA/PTPRC/FTL/FASLG/SRGN/APOE/CLIC2/CCR5/FTH1/TMSB4X,11
GO:0043368,positive T cell selection,5/213,35/15305,1.1508826085291379e-4,0.0014920914171371157,0.0011522168104866261,CD74/TBX21/PTPRC/CTSL/SLAMF6,5
GO:0031342,negative regulation of cell killing,4/213,19/15305,1.1996864309427159e-4,0.0015417804219495252,0.0011905874531856233,FCGR2B/PTPRC/HLA-E/HLA-A,4
GO:0046514,ceramide catabolic process,4/213,19/15305,1.1996864309427159e-4,0.0015417804219495252,0.0011905874531856233,ASAH1/GM2A/PSAP/HEXA,4
GO:0038094,Fc-gamma receptor signaling pathway,7/213,80/15305,1.2311314970792935e-4,0.0015743403040154916,0.0012157307138685718,FCGR2B/PTPRC/RAP1A/MYO1G/FCGR2A/FCER1G/FCGR3A,7
GO:0032640,tumor necrosis factor production,8/213,107/15305,1.2357207279224553e-4,0.0015743403040154916,0.0012157307138685718,CYBA/PTPRC/ACP5/SASH3/TLR4/FCER1G/CD14/HLA-E,8
GO:0072503,cellular divalent inorganic cation homeostasis,17/213,436/15305,1.3135665598531664e-4,0.001666304476572357,0.0012867469159360192,CD4/BAK1/HERPUD1/CYBA/PTPRC/PIK3CG/CCL8/FASLG/CXCR4/APOE/CLIC2/CCR5/CCR1/CD52/C3AR1/TRPV2/CCL5,17
GO:0070371,ERK1 and ERK2 cascade,13/213,279/15305,1.486635535611604e-4,0.0018777546700879616,0.001450032130736595,CD4/MARCO/CD74/PTPRC/CCL8/RAP1A/APOE/TLR4/CCR1/CCL5/CCL4/CCL18/CCL4L2,13
GO:0071706,tumor necrosis factor superfamily cytokine production,8/213,110/15305,1.4989959542851787e-4,0.0018778579194650758,0.0014501118615537667,CYBA/PTPRC/ACP5/SASH3/TLR4/FCER1G/CD14/HLA-E,8
GO:0045454,cell redox homeostasis,6/213,58/15305,1.499478800796102e-4,0.0018778579194650758,0.0014501118615537667,CYBA/NCF4/PRDX1/RAC2/CYBB/GPX1,6
GO:0002707,negative regulation of lymphocyte mediated immunity,5/213,37/15305,1.5108224814327085e-4,0.0018840468486679921,0.0014548910514777956,FCGR2B/TBX21/PTPRC/HLA-E/HLA-A,5
GO:0030099,myeloid cell differentiation,16/213,400/15305,1.552360416086639e-4,0.00192767793440632,0.001488583672365558,CD4/TYROBP/CD74/SNX10/DNASE2/SMAP1/LGALS3/TLR4/FCER1G/C1QC/CCR1/HCLS1/CSF1/EVI2B/LILRB4/CEBPA,16
GO:0045637,regulation of myeloid cell differentiation,12/213,243/15305,1.560281949744557e-4,0.0019293738563437946,0.0014898932903575845,CD4/TYROBP/CD74/SMAP1/LGALS3/TLR4/C1QC/CCR1/HCLS1/CSF1/EVI2B/LILRB4,12
GO:0002431,Fc receptor mediated stimulatory signaling pathway,7/213,84/15305,1.674951835465427e-4,0.002062503452625419,0.0015926980897466888,FCGR2B/PTPRC/RAP1A/MYO1G/FCGR2A/FCER1G/FCGR3A,7
GO:0002714,positive regulation of B cell mediated immunity,5/213,38/15305,1.7202051728200594e-4,0.002083359598193183,0.0016088035382796225,TBX21/PTPRC/FCER1G/TNFSF13/HLA-E,5
GO:0002891,positive regulation of immunoglobulin mediated immune response,5/213,38/15305,1.7202051728200594e-4,0.002083359598193183,0.0016088035382796225,TBX21/PTPRC/FCER1G/TNFSF13/HLA-E,5
GO:0030890,positive regulation of B cell proliferation,5/213,38/15305,1.7202051728200594e-4,0.002083359598193183,0.0016088035382796225,CD74/PTPRC/SASH3/TLR4/CARD11,5
GO:0042269,regulation of natural killer cell mediated cytotoxicity,5/213,38/15305,1.7202051728200594e-4,0.002083359598193183,0.0016088035382796225,LAG3/SLAMF6/SH2D1A/HLA-E/HLA-A,5
GO:0007204,positive regulation of cytosolic calcium ion concentration,13/213,284/15305,1.7713094459003285e-4,0.002136460532493716,0.0016498089273937918,CD4/BAK1/CYBA/PTPRC/PIK3CG/FASLG/CXCR4/CLIC2/CCR5/CCR1/CD52/C3AR1/TRPV2,13
GO:0002228,natural killer cell mediated immunity,6/213,60/15305,1.8123853606535358e-4,0.0021508234870484225,0.001660900230175991,LAG3/PRDX1/SLAMF6/SH2D1A/HLA-E/HLA-A,6
GO:0001573,ganglioside metabolic process,4/213,21/15305,1.8124506448794045e-4,0.0021508234870484225,0.001660900230175991,ST8SIA4/GM2A/HEXA/B3GALT4,4
GO:0006925,inflammatory cell apoptotic process,4/213,21/15305,1.8124506448794045e-4,0.0021508234870484225,0.001660900230175991,FASLG/CTSL/CCR5/CCL5,4
GO:0032928,regulation of superoxide anion generation,4/213,21/15305,1.8124506448794045e-4,0.0021508234870484225,0.001660900230175991,TYROBP/CYBA/ACP5/ITGB2,4
GO:0002369,T cell cytokine production,5/213,39/15305,1.9510328520607088e-4,0.0023059797926163316,0.0017807144060871148,TNFRSF1B/TBX21/STARD7/SASH3/HLA-A,5
GO:0043410,positive regulation of MAPK cascade,18/213,497/15305,2.0843383832701924e-4,0.0024536831447856708,0.001894773292412777,CD4/MARCO/CD74/FCGR2B/MYDGF/PTPRC/PIK3CG/CCL8/RAP1A/CXCR4/APOE/TLR4/CCR1/PSAP/CCL5/CCL4/CCL18/CCL4L2,18
GO:0048246,macrophage chemotaxis,5/213,40/15305,2.2047363660623613e-4,0.002585075348733677,0.001996236449707963,LGALS3/SLAMF8/C3AR1/CSF1/CCL5,5
GO:0006898,receptor-mediated endocytosis,12/213,253/15305,2.267538988972093e-4,0.002648161604978123,0.0020449526638223682,MARCO/MSR1/FCGR2B/SMAP1/SNX17/APOE/APOC1/CTSL/FCER1G/ITGB2/CD14/CD163,12
GO:0006687,glycosphingolipid metabolic process,6/213,63/15305,2.376076275236088e-4,0.0027639495960552598,0.0021343659988494754,ASAH1/ST8SIA4/GM2A/PSAP/HEXA/B3GALT4,6
GO:0030225,macrophage differentiation,5/213,41/15305,2.482788104630835e-4,0.002876710784223838,0.0022214419883539054,CD4/C1QC/HCLS1/CSF1/CEBPA,5
GO:0030316,osteoclast differentiation,7/213,90/15305,2.5754315372616114e-4,0.0029723509859454597,0.0022952968788226293,TYROBP/SNX10/TLR4/FCER1G/CCR1/CSF1/LILRB4,7
GO:0002637,regulation of immunoglobulin production,6/213,64/15305,2.5918253749017677e-4,0.0029795867493499616,0.0023008844508276794,FCGR2B/TBX21/PTPRC/SASH3/TNFSF13/HLA-E,6
GO:0002639,positive regulation of immunoglobulin production,5/213,42/15305,2.786700907784277e-4,0.003178783244809739,0.0024547071643844366,TBX21/PTPRC/SASH3/TNFSF13/HLA-E,5
GO:0002715,regulation of natural killer cell mediated immunity,5/213,42/15305,2.786700907784277e-4,0.003178783244809739,0.0024547071643844366,LAG3/SLAMF6/SH2D1A/HLA-E/HLA-A,5
GO:0032102,negative regulation of response to external stimulus,14/213,339/15305,2.905590221783851e-4,0.00330160309757138,0.00254955061525354,TNFRSF1B/GRN/FCGR2B/CST7/PTPRC/SAMHD1/ACP5/FGL2/APOE/SLAMF8/AIF1/HLA-E/HLA-A/GPX1,14
GO:1901214,regulation of neuron death,13/213,299/15305,2.9233719646335046e-4,0.003309032189198617,0.002555287478398274,TYROBP/TNFRSF1B/GRN/FCGR2B/LGMN/CTSZ/FASLG/APOE/TLR4/ITGB2/C1QA/CSF1/CCL5,13
GO:0002291,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,3/213,10/15305,2.967376050788591e-4,0.0033332014188819934,0.002573951343371863,FGL2/LGALS3/HLA-DMB,3
GO:0002524,hypersensitivity,3/213,10/15305,2.967376050788591e-4,0.0033332014188819934,0.002573951343371863,FCGR2B/FCER1G/HLA-E,3
GO:0070838,divalent metal ion transport,16/213,424/15305,2.992935233416175e-4,0.003349128666138328,0.002586250617948978,CD4/BAK1/CYBA/PTPRC/PIK3CG/CCL8/FASLG/CXCR4/LGALS3/CLIC2/CCR5/CCR1/MMGT1/TRPV2/CCL5/CCL4,16
GO:0006816,calcium ion transport,15/213,382/15305,3.039197016407119e-4,0.0033880139466992997,0.0026162784523217583,CD4/BAK1/CYBA/PTPRC/PIK3CG/CCL8/FASLG/CXCR4/LGALS3/CLIC2/CCR5/CCR1/TRPV2/CCL5/CCL4,15
GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,4/213,24/15305,3.114327348897091e-4,0.0034586661840770336,0.002670837237842629,LAG3/SLAMF6/SH2D1A/HLA-E,4
GO:0051924,regulation of calcium ion transport,11/213,226/15305,3.3150746082037175e-4,0.0036677686360690005,0.002832309489161783,CD4/BAK1/CYBA/PIK3CG/CXCR4/LGALS3/CLIC2/CCR1/TRPV2/CCL5/CCL4,11
GO:0030449,regulation of complement activation,5/213,44/15305,0.00034783564606365213,0.0038340086380723904,0.0029606826723888226,C1QC/C2/C3AR1/C1QB/C1QA,5
GO:0032677,regulation of interleukin-8 production,6/213,68/15305,3.613324047450827e-4,0.003967915175987979,0.003064087438509951,CD74/PTPRC/TLR8/TLR4/CD14/TMSB4X,6
GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,7/213,96/15305,3.8301223989618263e-4,0.004174833414868391,0.003223873005597888,CYBA/NCF4/FCER1G/CYBB/HLA-E/HLA-A/IFI30,7
GO:0032963,collagen metabolic process,7/213,96/15305,3.8301223989618263e-4,0.004174833414868391,0.003223873005597888,CST3/RAP1A/CTSD/PEPD/CTSL/CTSS/CTSB,7
GO:0051607,defense response to virus,11/213,230/15305,3.8481560156863794e-4,0.004179012234009231,0.0032270999564447053,PTPRC/SAMHD1/TLR8/BNIP3L/UNC93B1/IRF1/FGL2/RNASE6/PRF1/APOBEC3G/IL10RB,11
GO:0045657,positive regulation of monocyte differentiation,3/213,11/15305,4.038336158498712e-4,0.004337526757102813,0.003349507401536197,CD4/CD74/CSF1,3
GO:0071888,macrophage apoptotic process,3/213,11/15305,4.038336158498712e-4,0.004337526757102813,0.003349507401536197,CTSL/CCR5/CCL5,3
GO:0098883,synapse pruning,3/213,11/15305,4.038336158498712e-4,0.004337526757102813,0.003349507401536197,C1QC/C1QB/C1QA,3
GO:0006672,ceramide metabolic process,7/213,97/15305,4.0800399341743516e-4,0.004366384555009133,0.0033717918537348995,ASAH1/ST8SIA4/SGPL1/GM2A/PSAP/HEXA/B3GALT4,7
GO:0002861,regulation of inflammatory response to antigenic stimulus,4/213,26/15305,4.2872045590715323e-4,0.004511798306160164,0.003484082673605449,FCGR2B/FCER1G/HLA-E/GPX1,4
GO:0032743,positive regulation of interleukin-2 production,4/213,26/15305,4.2872045590715323e-4,0.004511798306160164,0.003484082673605449,CD4/PTPRC/SASH3/CARD11,4
GO:0002704,negative regulation of leukocyte mediated immunity,5/213,46/15305,4.2925705936963844e-4,0.004511798306160164,0.003484082673605449,FCGR2B/TBX21/PTPRC/HLA-E/HLA-A,5
GO:0032663,regulation of interleukin-2 production,5/213,46/15305,4.2925705936963844e-4,0.004511798306160164,0.003484082673605449,CD4/TBX21/PTPRC/SASH3/CARD11,5
GO:2000107,negative regulation of leukocyte apoptotic process,5/213,46/15305,4.2925705936963844e-4,0.004511798306160164,0.003484082673605449,CD74/FCER1G/CCR5/HCLS1/CCL5,5
GO:0010959,regulation of metal ion transport,14/213,353/15305,4.365331343264659e-4,0.004571946670187861,0.0035305302004526684,CD4/BAK1/CYBA/KCNAB2/ATP1B3/PIK3CG/CXCR4/LGALS3/ISCU/CLIC2/CCR1/TRPV2/CCL5/CCL4,14
GO:0042743,hydrogen peroxide metabolic process,5/213,47/15305,4.749815386428958e-4,0.004956988185198731,0.0038278654047406192,CYBA/PRDX1/RAC2/CYBB/GPX1,5
GO:0051480,regulation of cytosolic calcium ion concentration,13/213,315/15305,4.8054422113896913e-4,0.004997320292621859,0.0038590105019119746,CD4/BAK1/CYBA/PTPRC/PIK3CG/FASLG/CXCR4/CLIC2/CCR5/CCR1/CD52/C3AR1/TRPV2,13
GO:0006958,"complement activation, classical pathway",4/213,27/15305,4.978316701958114e-4,0.005158868328824904,0.003983760474250396,C1QC/C2/C1QB/C1QA,4
GO:0045089,positive regulation of innate immune response,10/213,201/15305,5.193143026725266e-4,0.005362603483386827,0.004141088012816195,LAG3/TLR8/TLR4/GBP5/FCER1G/SLAMF6/SH2D1A/CARD11/HLA-E/CCL5,10
GO:0034381,plasma lipoprotein particle clearance,5/213,48/15305,5.242781492108008e-4,0.005394932143802052,0.004166052720449462,MSR1/LIPA/NPC2/APOE/APOC1,5
GO:0002679,respiratory burst involved in defense response,3/213,12/15305,5.329314355552738e-4,0.005427049186294709,0.004190854013344877,GRN/PIK3CG/SLAMF8,3
GO:0042340,keratan sulfate catabolic process,3/213,12/15305,5.329314355552738e-4,0.005427049186294709,0.004190854013344877,OMD/GNS/HEXA,3
GO:1902563,regulation of neutrophil activation,3/213,12/15305,5.329314355552738e-4,0.005427049186294709,0.004190854013344877,GRN/FCGR2B/ITGB2,3
GO:0060759,regulation of response to cytokine stimulus,9/213,167/15305,5.552002719287712e-4,0.005634325518228875,0.004350916105605143,CD74/PTPRC/RFFL/SAMHD1/ELF1/CXCR4/TLR4/CSF1/CCL5,9
GO:0002717,positive regulation of natural killer cell mediated immunity,4/213,28/15305,5.74518180153284e-4,0.00581033334773579,0.004486832161153699,LAG3/SLAMF6/SH2D1A/HLA-E,4
GO:0002437,inflammatory response to antigenic stimulus,5/213,49/15305,5.773231080626928e-4,0.0058187051610565236,0.0044932970090387665,FCGR2B/CD68/FCER1G/HLA-E/GPX1,5
GO:0048872,homeostasis of number of cells,11/213,243/15305,6.103709943477593e-4,0.006130791250394047,0.004734294869038307,CD74/BAK1/DNASE2/LIPA/SMAP1/PRDX1/SASH3/FCER1G/HCLS1/CSF1/CARD11,11
GO:0032637,interleukin-8 production,6/213,75/15305,6.132934766773634e-4,0.006139192863474423,0.004740782728773461,CD74/PTPRC/TLR8/TLR4/CD14/TMSB4X,6
GO:0022408,negative regulation of cell-cell adhesion,9/213,170/15305,6.31298964207013e-4,0.006298009666648269,0.004863423599368211,CD74/FCGR2B/TBX21/LAG3/IRF1/FGL2/LGALS3/CTLA4/TIGIT,9
GO:0071622,regulation of granulocyte chemotaxis,5/213,50/15305,6.3429567477504e-4,0.0063065276042666985,0.004870001286768533,CD74/RAC2/C3AR1/CSF1/CCL5,5
GO:0006664,glycolipid metabolic process,7/213,105/15305,6.583964949234001e-4,0.006467066424778418,0.004993971926640057,ASAH1/ST8SIA4/FUCA1/GM2A/PSAP/HEXA/B3GALT4,7
GO:0002724,regulation of T cell cytokine production,4/213,29/15305,6.592320514554962e-4,0.006467066424778418,0.004993971926640057,TNFRSF1B/TBX21/SASH3/HLA-A,4
GO:0010758,regulation of macrophage chemotaxis,4/213,29/15305,6.592320514554962e-4,0.006467066424778418,0.004993971926640057,SLAMF8/C3AR1/CSF1/CCL5,4
GO:0045589,regulation of regulatory T cell differentiation,4/213,29/15305,6.592320514554962e-4,0.006467066424778418,0.004993971926640057,LAG3/IRF1/CTLA4/LILRB4,4
GO:0006596,polyamine biosynthetic process,3/213,13/15305,6.857215289012388e-4,0.006616650687069987,0.00510948328178697,SMS/OAZ1/SAT1,3
GO:0033033,negative regulation of myeloid cell apoptotic process,3/213,13/15305,6.857215289012388e-4,0.006616650687069987,0.00510948328178697,FCER1G/CCR5/CCL5,3
GO:0035723,interleukin-15-mediated signaling pathway,3/213,13/15305,6.857215289012388e-4,0.006616650687069987,0.00510948328178697,CD4/IL2RB/IL2RG,3
GO:0046479,glycosphingolipid catabolic process,3/213,13/15305,6.857215289012388e-4,0.006616650687069987,0.00510948328178697,GM2A/PSAP/HEXA,3
GO:0071350,cellular response to interleukin-15,3/213,13/15305,6.857215289012388e-4,0.006616650687069987,0.00510948328178697,CD4/IL2RB/IL2RG,3
GO:1903509,liposaccharide metabolic process,7/213,106/15305,6.967692225444586e-4,0.006701280463883469,0.005174835746382821,ASAH1/ST8SIA4/FUCA1/GM2A/PSAP/HEXA/B3GALT4,7
GO:0001818,negative regulation of cytokine production,11/213,248/15305,7.224016356396995e-4,0.006902688356128687,0.005330366135837701,TYROBP/SERPINB1/FCGR2B/TBX21/PTPRC/TLR8/ACP5/SRGN/TLR4/TIGIT/TMSB4X,11
GO:0072593,reactive oxygen species metabolic process,11/213,248/15305,7.224016356396995e-4,0.006902688356128687,0.005330366135837701,TYROBP/CYBA/NCF4/ACP5/PRDX1/RAC2/TLR4/ITGB2/CYBB/AIF1/GPX1,11
GO:0019722,calcium-mediated signaling,10/213,210/15305,7.296504376839065e-4,0.0069493891200768185,0.005366429211240178,CD4/PTPRC/SLA2/PLEK/PPP3CC/CXCR4/CLIC2/CCR5/CCR1/CCL4,10
GO:0030851,granulocyte differentiation,4/213,30/15305,7.524278464390864e-4,0.007083769497690904,0.005470199883940364,C1QC/HCLS1/EVI2B/CEBPA,4
GO:0033028,myeloid cell apoptotic process,4/213,30/15305,7.524278464390864e-4,0.007083769497690904,0.005470199883940364,CTSL/FCER1G/CCR5/CCL5,4
GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,6/213,78/15305,7.557946388973647e-4,0.007083769497690904,0.005470199883940364,FCGR2B/PTPRC/RAP1A/MYO1G/FCGR2A/FCGR3A,6
GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,6/213,78/15305,7.557946388973647e-4,0.007083769497690904,0.005470199883940364,FCGR2B/PTPRC/RAP1A/MYO1G/FCGR2A/FCGR3A,6
GO:0097006,regulation of plasma lipoprotein particle levels,6/213,78/15305,7.557946388973647e-4,0.007083769497690904,0.005470199883940364,MSR1/LIPA/NPC2/APOE/APOC1/PLA2G7,6
GO:0038093,Fc receptor signaling pathway,9/213,176/15305,8.091588484536034e-4,0.0075598555269808096,0.005837841115493165,LCP2/FCGR2B/PTPRC/RAP1A/MYO1G/FCGR2A/FCER1G/CARD11/FCGR3A,9
GO:0051928,positive regulation of calcium ion transport,7/213,109/15305,8.226202000131165e-4,0.007661301419742411,0.00591617925325889,CD4/BAK1/LGALS3/CCR1/TRPV2/CCL5/CCL4,7
GO:0045824,negative regulation of innate immune response,5/213,53/15305,8.306143780220143e-4,0.0076871009890527925,0.005936102092517474,GRN/SAMHD1/SLAMF8/HLA-E/HLA-A,5
GO:1905517,macrophage migration,5/213,53/15305,8.306143780220143e-4,0.0076871009890527925,0.005936102092517474,LGALS3/SLAMF8/C3AR1/CSF1/CCL5,5
GO:0002864,regulation of acute inflammatory response to antigenic stimulus,3/213,14/15305,8.638119293600081e-4,0.00787366508585453,0.006080169866180208,FCGR2B/FCER1G/HLA-E,3
GO:0043374,"CD8-positive, alpha-beta T cell differentiation",3/213,14/15305,8.638119293600081e-4,0.00787366508585453,0.006080169866180208,TNFSF8/IRF1/EOMES,3
GO:0060263,regulation of respiratory burst,3/213,14/15305,8.638119293600081e-4,0.00787366508585453,0.006080169866180208,GRN/RAC2/SLAMF8,3
GO:0070672,response to interleukin-15,3/213,14/15305,8.638119293600081e-4,0.00787366508585453,0.006080169866180208,CD4/IL2RB/IL2RG,3
GO:2000106,regulation of leukocyte apoptotic process,6/213,80/15305,8.641501266500216e-4,0.00787366508585453,0.006080169866180208,CD74/LGALS3/FCER1G/CCR5/HCLS1/CCL5,6
GO:0043270,positive regulation of ion transport,11/213,254/15305,8.789195513389413e-4,0.007983519257995383,0.00616500101150349,CD4/BAK1/ATP1B3/APOE/LGALS3/CTSS/CCR1/TRPV2/TMSB4X/CCL5/CCL4,11
GO:0070997,neuron death,13/213,337/15305,8.998576626939006e-4,0.008148557234794306,0.006292445971679778,TYROBP/TNFRSF1B/GRN/FCGR2B/LGMN/CTSZ/FASLG/APOE/TLR4/ITGB2/C1QA/CSF1/CCL5,13
GO:0010332,response to gamma radiation,5/213,54/15305,9.051460127129092e-4,0.008171302808018687,0.0063100104664099805,BAK1/CYBA/PTPRC/TMEM109/GPX1,5
GO:0060402,calcium ion transport into cytosol,8/213,145/15305,9.63214486117743e-4,0.008641968359009305,0.006673465918093276,CD4/BAK1/CYBA/PTPRC/FASLG/CLIC2/CCR5/TRPV2,8
GO:0002888,positive regulation of myeloid leukocyte mediated immunity,4/213,32/15305,9.660916038443972e-4,0.008641968359009305,0.006673465918093276,TYROBP/FCER1G/ITGB2/HLA-E,4
GO:0045066,regulatory T cell differentiation,4/213,32/15305,9.660916038443972e-4,0.008641968359009305,0.006673465918093276,LAG3/IRF1/CTLA4/LILRB4,4
GO:0032611,interleukin-1 beta production,6/213,82/15305,9.841037631372195e-4,0.008776416287614656,0.00677728875474723,TYROBP/SERPINB1/TLR8/ACP5/TLR4/GBP5,6
GO:0030852,regulation of granulocyte differentiation,3/213,15/15305,0.0010687306103404394,0.009476087944997456,0.0073175863773984684,C1QC/HCLS1/EVI2B,3
GO:0006956,complement activation,5/213,56/15305,0.0010689980284536715,0.009476087944997456,0.0073175863773984684,C1QC/C2/C3AR1/C1QB/C1QA,5
GO:0090322,regulation of superoxide metabolic process,4/213,33/15305,0.0010874747807736508,0.009610925765215779,0.007421710294579776,TYROBP/CYBA/ACP5/ITGB2,4
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,5/213,57/15305,0.0011587096735832907,0.010209828051962948,0.00788419220065025,RFFL/FASLG/LGALS3/TMBIM1/GPX1,5
GO:0002832,negative regulation of response to biotic stimulus,6/213,85/15305,0.0011875593781408632,0.010401747767465953,0.00803239566856555,GRN/SAMHD1/FGL2/SLAMF8/HLA-E/HLA-A,6
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,6/213,85/15305,0.0011875593781408632,0.010401747767465953,0.00803239566856555,RFFL/FASLG/LGALS3/TMBIM1/GABARAP/GPX1,6
GO:0001914,regulation of T cell mediated cytotoxicity,4/213,34/15305,0.0012191690103109645,0.010552983521603438,0.008149182332078553,FCGR2B/PTPRC/HLA-E/HLA-A,4
GO:0034142,toll-like receptor 4 signaling pathway,4/213,34/15305,0.0012191690103109645,0.010552983521603438,0.008149182332078553,TLR4/PIK3AP1/ITGB2/CD14,4
GO:0046640,regulation of alpha-beta T cell proliferation,4/213,34/15305,0.0012191690103109645,0.010552983521603438,0.008149182332078553,PTPRC/IRF1/HLA-E/HLA-A,4
GO:0097242,amyloid-beta clearance,4/213,34/15305,0.0012191690103109645,0.010552983521603438,0.008149182332078553,MARCO/MSR1/APOE/ITGB2,4
GO:0006595,polyamine metabolic process,3/213,16/15305,0.0013019278012534256,0.011166806949349024,0.00862318658141336,SMS/OAZ1/SAT1,3
GO:0032695,negative regulation of interleukin-12 production,3/213,16/15305,0.0013019278012534256,0.011166806949349024,0.00862318658141336,TLR8/ACP5/TIGIT,3
GO:0097067,cellular response to thyroid hormone stimulus,3/213,16/15305,0.0013019278012534256,0.011166806949349024,0.00862318658141336,CTSL/CTSS/CTSB,3
GO:0016125,sterol metabolic process,8/213,152/15305,0.0013052604792986968,0.011166806949349024,0.00862318658141336,LIPA/SNX17/NPC2/APOE/APOC1/FDX1/PIP4P1/CEBPA,8
GO:0007162,negative regulation of cell adhesion,11/213,267/15305,0.0013157828908336787,0.011224200138329032,0.008667506518108048,CD74/FCGR2B/TBX21/PTPRC/LAG3/IRF1/FGL2/LGALS3/ADAMDEC1/CTLA4/TIGIT,11
GO:0002755,MyD88-dependent toll-like receptor signaling pathway,4/213,35/15305,0.0013616310424991018,0.011548357804250307,0.008917826242243472,TLR8/IRF1/TLR4/CD14,4
GO:0032733,positive regulation of interleukin-10 production,4/213,35/15305,0.0013616310424991018,0.011548357804250307,0.008917826242243472,SASH3/TLR4/FCER1G/TIGIT,4
GO:0016042,lipid catabolic process,12/213,310/15305,0.0013691408648020356,0.011578682658368939,0.008941243578667862,ASAH1/PIK3CG/LIPA/SNX17/APOE/APOC1/PLA2G7/SGPL1/FUCA1/GM2A/PSAP/HEXA,12
GO:0032675,regulation of interleukin-6 production,7/213,119/15305,0.001376389731611678,0.01160663318089733,0.008962827418336943,TYROBP/CD74/CYBA/TLR8/TLR4/FCER1G/AIF1,7
GO:0045670,regulation of osteoclast differentiation,5/213,60/15305,0.001461375051610465,0.012288076505398855,0.00948904883135938,TYROBP/TLR4/CCR1/CSF1/LILRB4,5
GO:0010543,regulation of platelet activation,4/213,36/15305,0.0015153162163233753,0.012705343659942147,0.009811269188910383,PLEK/APOE/TLR4/FCER1G,4
GO:0001959,regulation of cytokine-mediated signaling pathway,8/213,156/15305,0.0015403154028403674,0.012878262018634096,0.009944799505778569,CD74/PTPRC/RFFL/SAMHD1/ELF1/CXCR4/CSF1/CCL5,8
GO:0002710,negative regulation of T cell mediated immunity,3/213,17/15305,0.0015647782496076572,0.013008876803941624,0.010045662327989688,FCGR2B/TBX21/PTPRC,3
GO:0030889,negative regulation of B cell proliferation,3/213,17/15305,0.0015647782496076572,0.013008876803941624,0.010045662327989688,TYROBP/FCGR2B/CTLA4,3
GO:0046633,alpha-beta T cell proliferation,4/213,37/15305,0.0016806779094361152,0.013933056584423906,0.010759328707109184,PTPRC/IRF1/HLA-E/HLA-A,4
GO:0032612,interleukin-1 production,6/213,92/15305,0.00178695854985263,0.014772525315214299,0.01140757986141877,TYROBP/SERPINB1/TLR8/ACP5/TLR4/GBP5,6
GO:0050663,cytokine secretion,5/213,63/15305,0.0018185921357468185,0.014991923404769989,0.011577002568413331,LCP2/FCGR2B/TLR8/SRGN/CD14,5
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,4/213,38/15305,0.0018581670143954243,0.015193919542291781,0.011732987210260906,RFFL/FASLG/TMBIM1/GPX1,4
GO:0032930,positive regulation of superoxide anion generation,3/213,18/15305,0.001858583430249759,0.015193919542291781,0.011732987210260906,TYROBP/CYBA/ITGB2,3
GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation",3/213,18/15305,0.001858583430249759,0.015193919542291781,0.011732987210260906,IRF1/HLA-E/HLA-A,3
GO:0046634,regulation of alpha-beta T cell activation,6/213,93/15305,0.0018884524576151997,0.015395334024270173,0.011888522688412936,TBX21/PTPRC/SASH3/IRF1/HLA-E/HLA-A,6
GO:0030101,natural killer cell activation,5/213,65/15305,0.002089785284896218,0.016989607992954615,0.013119646496338861,TYROBP/PTPRC/PRDX1/ITGB2/HLA-E,5
GO:0060401,cytosolic calcium ion transport,8/213,164/15305,0.0021106441918681,0.017111916960517407,0.013214095433502184,CD4/BAK1/CYBA/PTPRC/FASLG/CLIC2/CCR5/TRPV2,8
GO:0010759,positive regulation of macrophage chemotaxis,3/213,19/15305,0.0021845737028414122,0.017388870778100127,0.01342796359243814,C3AR1/CSF1/CCL5,3
GO:0043373,"CD4-positive, alpha-beta T cell lineage commitment",3/213,19/15305,0.0021845737028414122,0.017388870778100127,0.01342796359243814,TBX21/CTSL/SLAMF6,3
GO:0045655,regulation of monocyte differentiation,3/213,19/15305,0.0021845737028414122,0.017388870778100127,0.01342796359243814,CD4/CD74/CSF1,3
GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,3/213,19/15305,0.0021845737028414122,0.017388870778100127,0.01342796359243814,CD74/TLR4/FCER1G,3
GO:0150146,cell junction disassembly,3/213,19/15305,0.0021845737028414122,0.017388870778100127,0.01342796359243814,C1QC/C1QB/C1QA,3
GO:1900017,positive regulation of cytokine production involved in inflammatory response,3/213,19/15305,0.0021845737028414122,0.017388870778100127,0.01342796359243814,TLR4/GBP5/GPSM3,3
GO:0046718,viral entry into host cell,7/213,129/15305,0.0021861645218814296,0.017388870778100127,0.01342796359243814,CD4/CD74/SELPLG/CXCR4/CTSL/CCR5/CTSB,7
GO:0002292,T cell differentiation involved in immune response,5/213,66/15305,0.0022359203493308474,0.017736694307495103,0.013696558474124841,TBX21/FGL2/FCER1G/SLAMF6/EOMES,5
GO:0032635,interleukin-6 production,7/213,130/15305,0.002283888932699007,0.01806850841111069,0.013952790621667108,TYROBP/CD74/CYBA/TLR8/TLR4/FCER1G/AIF1,7
GO:0070227,lymphocyte apoptotic process,5/213,67/15305,0.002389360171743333,0.018852243928795254,0.014558003699150153,CD74/BAK1/FASLG/LGALS3/CCL5,5
GO:0035821,modulation of process of other organism,6/213,98/15305,0.0024628631887012946,0.019265019789013387,0.014876755807528981,CD4/CCL8/APOE/MPEG1/CCL5/CCL4,6
GO:0002673,regulation of acute inflammatory response,4/213,41/15305,0.002467860163254518,0.019265019789013387,0.014876755807528981,FCGR2B/PIK3CG/FCER1G/HLA-E,4
GO:1902622,regulation of neutrophil migration,4/213,41/15305,0.002467860163254518,0.019265019789013387,0.014876755807528981,CD74/RAC2/SLAMF8/C3AR1,4
GO:1905521,regulation of macrophage migration,4/213,41/15305,0.002467860163254518,0.019265019789013387,0.014876755807528981,SLAMF8/C3AR1/CSF1/CCL5,4
GO:0045649,regulation of macrophage differentiation,3/213,20/15305,0.002543910418645353,0.019806159688024533,0.015294632675731877,C1QC/HCLS1/CSF1,3
GO:0002363,alpha-beta T cell lineage commitment,3/213,21/15305,0.0029376879776715904,0.022496642301524306,0.0173722662979026,TBX21/CTSL/SLAMF6,3
GO:0002438,acute inflammatory response to antigenic stimulus,3/213,21/15305,0.0029376879776715904,0.022496642301524306,0.0173722662979026,FCGR2B/FCER1G/HLA-E,3
GO:0042401,cellular biogenic amine biosynthetic process,3/213,21/15305,0.0029376879776715904,0.022496642301524306,0.0173722662979026,SMS/OAZ1/SAT1,3
GO:0043369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",3/213,21/15305,0.0029376879776715904,0.022496642301524306,0.0173722662979026,TBX21/CTSL/SLAMF6,3
GO:0045061,thymic T cell selection,3/213,21/15305,0.0029376879776715904,0.022496642301524306,0.0173722662979026,CD74/PTPRC/CARD11,3
GO:0046641,positive regulation of alpha-beta T cell proliferation,3/213,21/15305,0.0029376879776715904,0.022496642301524306,0.0173722662979026,PTPRC/HLA-E/HLA-A,3
GO:0008203,cholesterol metabolic process,7/213,136/15305,0.002942985826057376,0.022496642301524306,0.0173722662979026,SNX17/NPC2/APOE/APOC1/FDX1/PIP4P1/CEBPA,7
GO:0008202,steroid metabolic process,11/213,297/15305,0.0030246991923659166,0.02306137233972252,0.017808359848153845,LGMN/ASAH1/LIPA/SNX17/NPC2/APOE/APOC1/FDX1/PIP4P1/SGPL1/CEBPA,11
GO:0032418,lysosome localization,5/213,71/15305,0.0030803720704240217,0.023425155047178025,0.018089278661894363,PIK3CG/RAC2/BLOC1S1/FCER1G/PIP4P1,5
GO:0043300,regulation of leukocyte degranulation,4/213,44/15305,0.003202593769325569,0.02422939193605437,0.018710323225473963,FCGR2B/RAC2/FCER1G/ITGB2,4
GO:1900015,regulation of cytokine production involved in inflammatory response,4/213,44/15305,0.003202593769325569,0.02422939193605437,0.018710323225473963,PLD3/TLR4/GBP5/GPSM3,4
GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",5/213,72/15305,0.0032734914135232364,0.02470226982050996,0.01907548707637427,CYBA/NCF4/CYBB/HLA-E/HLA-A,5
GO:0009309,amine biosynthetic process,3/213,22/15305,0.0033669358372150743,0.025342435214639296,0.019569833012645973,SMS/OAZ1/SAT1,3
GO:0032481,positive regulation of type I interferon production,5/213,73/15305,0.0034751786418749393,0.025908030021671764,0.020006594351195287,TLR8/POLR3GL/IRF1/TLR4/CD14,5
GO:0032651,regulation of interleukin-1 beta production,5/213,73/15305,0.0034751786418749393,0.025908030021671764,0.020006594351195287,TYROBP/SERPINB1/TLR8/ACP5/TLR4,5
GO:1903409,reactive oxygen species biosynthetic process,6/213,105/15305,0.003476104030382718,0.025908030021671764,0.020006594351195287,CYBA/ACP5/TLR4/ITGB2/CYBB/AIF1,6
GO:0070231,T cell apoptotic process,4/213,45/15305,0.0034772925105539744,0.025908030021671764,0.020006594351195287,BAK1/FASLG/LGALS3/CCL5,4
GO:0044242,cellular lipid catabolic process,9/213,218/15305,0.0035129668032927407,0.026041968015341397,0.020110023407951816,ASAH1/PIK3CG/APOC1/PLA2G7/SGPL1/FUCA1/GM2A/PSAP/HEXA,9
GO:0097191,extrinsic apoptotic signaling pathway,9/213,218/15305,0.0035129668032927407,0.026041968015341397,0.020110023407951816,TNFRSF1B/BAK1/PTPRC/RFFL/FASLG/LGALS3/TMBIM1/GABARAP/GPX1,9
GO:0006826,iron ion transport,5/213,74/15305,0.0036856440912998545,0.027253393368581586,0.021045505403640273,FTL/ATP6V0E1/ISCU/FTH1/MMGT1,5
GO:0044409,entry into host,7/213,142/15305,0.0037388710030886317,0.02757768762428532,0.021295930604586087,CD4/CD74/SELPLG/CXCR4/CTSL/CCR5/CTSB,7
GO:0019835,cytolysis,3/213,23/15305,0.003832620472796371,0.02798859069836159,0.021613236517610986,GZMH/GZMA/PRF1,3
GO:0019883,antigen processing and presentation of endogenous antigen,3/213,23/15305,0.003832620472796371,0.02798859069836159,0.021613236517610986,CD74/HLA-E/HLA-A,3
GO:0043032,positive regulation of macrophage activation,3/213,23/15305,0.003832620472796371,0.02798859069836159,0.021613236517610986,CTSC/TLR4/CEBPA,3
GO:0045672,positive regulation of osteoclast differentiation,3/213,23/15305,0.003832620472796371,0.02798859069836159,0.021613236517610986,TYROBP/CCR1/CSF1,3
GO:0002534,cytokine production involved in inflammatory response,4/213,47/15305,0.0040738699790499435,0.029603455181096257,0.022860260649171744,PLD3/TLR4/GBP5/GPSM3,4
GO:0006968,cellular defense response,4/213,47/15305,0.0040738699790499435,0.029603455181096257,0.022860260649171744,TYROBP/CCR5/PRF1/SH2D1A,4
GO:0002312,B cell activation involved in immune response,5/213,76/15305,0.004133748919221695,0.029890965772160803,0.02308228091710756,FCGR2B/TBX21/PTPRC/TLR4/TNFSF13,5
GO:0071260,cellular response to mechanical stimulus,5/213,76/15305,0.004133748919221695,0.029890965772160803,0.02308228091710756,BAK1/CYBA/TLR8/IRF1/TLR4,5
GO:1902652,secondary alcohol metabolic process,7/213,145/15305,0.004193464597846704,0.030199954606648108,0.02332088702747045,SNX17/NPC2/APOE/APOC1/FDX1/PIP4P1/CEBPA,7
GO:0009636,response to toxic substance,9/213,224/15305,0.0041970035454023365,0.030199954606648108,0.02332088702747045,BAK1/CST3/AKR1A1/PRDX1/APOE/CLIC2/GPX1/CCL5/CCL4,9
GO:0071219,cellular response to molecule of bacterial origin,8/213,184/15305,0.004271189173275604,0.030658804236463662,0.023675218036205464,TNFRSF1B/FCGR2B/LY86/CD68/TLR4/CCR5/CD14/CCL5,8
GO:0032753,positive regulation of interleukin-4 production,3/213,24/15305,0.004335647292497322,0.03089542368479327,0.023857939351348844,SASH3/FCER1G/HLA-E,3
GO:0034162,toll-like receptor 9 signaling pathway,3/213,24/15305,0.004335647292497322,0.03089542368479327,0.023857939351348844,TLR8/UNC93B1/PIK3AP1,3
GO:0097066,response to thyroid hormone,3/213,24/15305,0.004335647292497322,0.03089542368479327,0.023857939351348844,CTSL/CTSS/CTSB,3
GO:0002711,positive regulation of T cell mediated immunity,4/213,49/15305,0.0047360478820510695,0.03358599739006336,0.025935643316038707,PTPRC/SASH3/HLA-E/HLA-A,4
GO:1903428,positive regulation of reactive oxygen species biosynthetic process,4/213,49/15305,0.0047360478820510695,0.03358599739006336,0.025935643316038707,CYBA/TLR4/ITGB2/AIF1,4
GO:0051702,interaction with symbiont,5/213,79/15305,0.004876972237124663,0.03450223387946606,0.026643175758988225,CCL8/APOE/GPX1/CCL5/CCL4,5
GO:0048771,tissue remodeling,7/213,150/15305,0.005042639562412622,0.035588700796595554,0.027482162855607353,BAK1/SNX10/CST3/ACP5/LIPA/RAC2/TMBIM1,7
GO:0032757,positive regulation of interleukin-8 production,4/213,50/15305,0.0050927219870315924,0.035770598586715933,0.027622627232762736,CD74/TLR8/TLR4/CD14,4
GO:0043277,apoptotic cell clearance,4/213,50/15305,0.0050927219870315924,0.035770598586715933,0.027622627232762736,TYROBP/MARCO/RAC2/C2,4
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,5/213,80/15305,0.0051444937111563074,0.03604820236174527,0.027836997299214204,MYDGF/PIK3CG/PIK3AP1/HCLS1/CCL5,5
GO:0070664,negative regulation of leukocyte proliferation,5/213,81/15305,0.005422248095429621,0.03752362782438695,0.028976344393601746,TYROBP/FCGR2B/CCL8/CTLA4/LST1,5
GO:0002675,positive regulation of acute inflammatory response,3/213,26/15305,0.005457054946937688,0.03752362782438695,0.028976344393601746,PIK3CG/FCER1G/HLA-E,3
GO:0033032,regulation of myeloid cell apoptotic process,3/213,26/15305,0.005457054946937688,0.03752362782438695,0.028976344393601746,FCER1G/CCR5/CCL5,3
GO:0034368,protein-lipid complex remodeling,3/213,26/15305,0.005457054946937688,0.03752362782438695,0.028976344393601746,APOE/APOC1/PLA2G7,3
GO:0034369,plasma lipoprotein particle remodeling,3/213,26/15305,0.005457054946937688,0.03752362782438695,0.028976344393601746,APOE/APOC1/PLA2G7,3
GO:0045830,positive regulation of isotype switching,3/213,26/15305,0.005457054946937688,0.03752362782438695,0.028976344393601746,TBX21/PTPRC/TNFSF13,3
GO:0090023,positive regulation of neutrophil chemotaxis,3/213,26/15305,0.005457054946937688,0.03752362782438695,0.028976344393601746,CD74/RAC2/C3AR1,3
GO:1905523,positive regulation of macrophage migration,3/213,26/15305,0.005457054946937688,0.03752362782438695,0.028976344393601746,C3AR1/CSF1/CCL5,3
GO:0032652,regulation of interleukin-1 production,5/213,82/15305,0.005710439285838219,0.0391321888306891,0.03021850088003926,TYROBP/SERPINB1/TLR8/ACP5/TLR4,5
GO:0001894,tissue homeostasis,9/213,235/15305,0.005717581106760555,0.0391321888306891,0.03021850088003926,SNX10/ACP5/LIPA/PRDX1/SASH3/RAC2/TLR4/CSF1/PECAM1,9
GO:0051897,positive regulation of protein kinase B signaling,7/213,154/15305,0.00581029913160109,0.0396401675420289,0.030610770149772124,MYDGF/PIK3CG/RAC2/PIK3AP1/ICOS/HCLS1/GPX1,7
GO:0031638,zymogen activation,4/213,52/15305,0.005859148107639337,0.0396401675420289,0.030610770149772124,BAK1/LGMN/CTSZ/CTSL,4
GO:0032655,regulation of interleukin-12 production,4/213,52/15305,0.005859148107639337,0.0396401675420289,0.030610770149772124,TLR8/ACP5/TLR4/TIGIT,4
GO:0050707,regulation of cytokine secretion,4/213,52/15305,0.005859148107639337,0.0396401675420289,0.030610770149772124,FCGR2B/TLR8/SRGN/CD14,4
GO:0050829,defense response to Gram-negative bacterium,4/213,52/15305,0.005859148107639337,0.0396401675420289,0.030610770149772124,CD4/TLR4/RNASE6/MPEG1,4
GO:0001916,positive regulation of T cell mediated cytotoxicity,3/213,27/15305,0.006076957856530423,0.040832162036002366,0.031531247325761076,PTPRC/HLA-E/HLA-A,3
GO:0002360,T cell lineage commitment,3/213,27/15305,0.006076957856530423,0.040832162036002366,0.031531247325761076,TBX21/CTSL/SLAMF6,3
GO:0034367,protein-containing complex remodeling,3/213,27/15305,0.006076957856530423,0.040832162036002366,0.031531247325761076,APOE/APOC1/PLA2G7,3
GO:0019058,viral life cycle,11/213,327/15305,0.006192875075882158,0.041516244529205444,0.03205950674698376,CD4/CD74/CCL8/SELPLG/CXCR4/APOE/CTSL/CCR5/CTSB/APOBEC3G/CCL5,11
GO:0034599,cellular response to oxidative stress,10/213,283/15305,0.006382999433539141,0.04264600170393285,0.03293192327156,CYBA/KEAP1/NCF4/CST3/PRDX1/TLR4/CYBB/PSAP/AIF1/GPX1,10
GO:0000041,transition metal ion transport,6/213,119/15305,0.006390379460222354,0.04264600170393285,0.03293192327156,FTL/ATP6V0E1/ISCU/FTH1/MMGT1/TCN2,6
GO:1903426,regulation of reactive oxygen species biosynthetic process,5/213,85/15305,0.006639652360485339,0.044159751821555446,0.03410086527629816,CYBA/ACP5/TLR4/ITGB2/AIF1,5
GO:0001960,negative regulation of cytokine-mediated signaling pathway,4/213,54/15305,0.006698800228538493,0.044159751821555446,0.03410086527629816,PTPRC/RFFL/SAMHD1/CCL5,4
GO:0032615,interleukin-12 production,4/213,54/15305,0.006698800228538493,0.044159751821555446,0.03410086527629816,TLR8/ACP5/TLR4/TIGIT,4
GO:0045428,regulation of nitric oxide biosynthetic process,4/213,54/15305,0.006698800228538493,0.044159751821555446,0.03410086527629816,ACP5/TLR4/ITGB2/AIF1,4
GO:0051452,intracellular pH reduction,4/213,54/15305,0.006698800228538493,0.044159751821555446,0.03410086527629816,GRN/ATP6V0E1/FASLG/SLAMF8,4
GO:0048873,homeostasis of number of cells within a tissue,3/213,28/15305,0.006737250617695683,0.044159751821555446,0.03410086527629816,LIPA/SASH3/CSF1,3
GO:0050849,negative regulation of calcium-mediated signaling,3/213,28/15305,0.006737250617695683,0.044159751821555446,0.03410086527629816,SLA2/PLEK/CLIC2,3
GO:0071624,positive regulation of granulocyte chemotaxis,3/213,28/15305,0.006737250617695683,0.044159751821555446,0.03410086527629816,CD74/RAC2/C3AR1,3
GO:0006665,sphingolipid metabolic process,7/213,159/15305,0.006889040981989959,0.04503148727313307,0.03477403330747154,ASAH1/ST8SIA4/SGPL1/GM2A/PSAP/HEXA/B3GALT4,7
GO:0048871,multicellular organismal homeostasis,14/213,476/15305,0.006900849731628615,0.04503148727313307,0.03477403330747154,STARD7/SNX10/ACP5/LIPA/PRDX1/CXCR4/SASH3/RAC2/TLR4/PCTP/CSF1/TRPV2/GPX1/PECAM1,14
GO:0031663,lipopolysaccharide-mediated signaling pathway,4/213,55/15305,0.007146977316068323,0.04643168706664255,0.035855289939331965,LY86/TLR4/CD14/CCL5,4
GO:0043525,positive regulation of neuron apoptotic process,4/213,55/15305,0.007146977316068323,0.04643168706664255,0.035855289939331965,TYROBP/GRN/CTSZ/FASLG,4
GO:0002576,platelet degranulation,6/213,122/15305,0.007194238054822814,0.046635776641725864,0.03601289116708198,PLEK/SRGN/FCER1G/PSAP/TMSB4X/PECAM1,6
GO:0050792,regulation of viral process,8/213,202/15305,0.0074027598801837255,0.0478820270931444,0.03697526565949488,CD4/CD74/CCL8/CXCR4/APOE/APOBEC3G/CCL5/CCL4,8
GO:0050690,regulation of defense response to virus by virus,3/213,29/15305,0.007438560452261859,0.04800807765571634,0.03707260391605115,CD4/CD8B/AP1S2,3
GO:0045576,mast cell activation,4/213,56/15305,0.007614514184346369,0.04892907258631302,0.03778381090324939,LCP2/PIK3CG/RAC2/FCER1G,4
GO:0045851,pH reduction,4/213,56/15305,0.007614514184346369,0.04892907258631302,0.03778381090324939,GRN/ATP6V0E1/FASLG/SLAMF8,4
